0001680132-22-000009.txt : 20220114 0001680132-22-000009.hdr.sgml : 20220114 20220114151149 ACCESSION NUMBER: 0001680132-22-000009 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20211130 FILED AS OF DATE: 20220114 DATE AS OF CHANGE: 20220114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CANNABIS SUISSE CORP. CENTRAL INDEX KEY: 0001680132 STANDARD INDUSTRIAL CLASSIFICATION: PAPERS & ALLIED PRODUCTS [2600] IRS NUMBER: 383993849 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-213009 FILM NUMBER: 22531724 BUSINESS ADDRESS: STREET 1: 6607 CLARA ST #270 CITY: BELL GARDENS STATE: CA ZIP: 90201 BUSINESS PHONE: 15022082098 MAIL ADDRESS: STREET 1: 6607 CLARA ST #270 CITY: BELL GARDENS STATE: CA ZIP: 90201 FORMER COMPANY: FORMER CONFORMED NAME: Geant Corp. DATE OF NAME CHANGE: 20160719 10-Q 1 cannabis10q_nov21.htm
0001680132 false --05-31 Q2 2022 true false 0001680132 2021-06-01 2021-11-30 0001680132 2022-01-14 0001680132 2021-11-30 0001680132 2021-05-31 0001680132 2021-09-01 2021-11-30 0001680132 2020-09-01 2020-11-30 0001680132 2020-06-01 2020-11-30 0001680132 us-gaap:PreferredStockMember 2020-05-31 0001680132 us-gaap:CommonStockMember 2020-05-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-05-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-05-31 0001680132 us-gaap:RetainedEarningsMember 2020-05-31 0001680132 2020-05-31 0001680132 us-gaap:PreferredStockMember 2020-06-01 2020-08-31 0001680132 us-gaap:CommonStockMember 2020-06-01 2020-08-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-06-01 2020-08-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-01 2020-08-31 0001680132 us-gaap:RetainedEarningsMember 2020-06-01 2020-08-31 0001680132 2020-06-01 2020-08-31 0001680132 us-gaap:PreferredStockMember 2020-08-31 0001680132 us-gaap:CommonStockMember 2020-08-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-08-31 0001680132 us-gaap:RetainedEarningsMember 2020-08-31 0001680132 2020-08-31 0001680132 us-gaap:PreferredStockMember 2020-09-01 2020-11-30 0001680132 us-gaap:CommonStockMember 2020-09-01 2020-11-30 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-09-01 2020-11-30 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-01 2020-11-30 0001680132 us-gaap:RetainedEarningsMember 2020-09-01 2020-11-30 0001680132 us-gaap:PreferredStockMember 2020-11-30 0001680132 us-gaap:CommonStockMember 2020-11-30 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-11-30 0001680132 us-gaap:RetainedEarningsMember 2020-11-30 0001680132 2020-11-30 0001680132 us-gaap:PreferredStockMember 2021-05-31 0001680132 us-gaap:CommonStockMember 2021-05-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-31 0001680132 us-gaap:RetainedEarningsMember 2021-05-31 0001680132 us-gaap:PreferredStockMember 2021-06-01 2021-08-31 0001680132 us-gaap:CommonStockMember 2021-06-01 2021-08-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-06-01 2021-08-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-01 2021-08-31 0001680132 us-gaap:RetainedEarningsMember 2021-06-01 2021-08-31 0001680132 2021-06-01 2021-08-31 0001680132 us-gaap:PreferredStockMember 2021-08-31 0001680132 us-gaap:CommonStockMember 2021-08-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-08-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-08-31 0001680132 us-gaap:RetainedEarningsMember 2021-08-31 0001680132 2021-08-31 0001680132 us-gaap:PreferredStockMember 2021-09-01 2021-11-30 0001680132 us-gaap:CommonStockMember 2021-09-01 2021-11-30 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-09-01 2021-11-30 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-01 2021-11-30 0001680132 us-gaap:RetainedEarningsMember 2021-09-01 2021-11-30 0001680132 us-gaap:PreferredStockMember 2021-11-30 0001680132 us-gaap:CommonStockMember 2021-11-30 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-11-30 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-11-30 0001680132 us-gaap:RetainedEarningsMember 2021-11-30 0001680132 2020-06-01 2021-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended: November 30, 2021

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ___________ to____________

Commission File Number: 333-213009

CANNABIS SUISSE CORP.

(Exact name of registrant as specified in its charter)

 

 

NV

(State or Other Jurisdiction of Incorporation or Organization)

2600

(Primary Standard Industrial Classification Code Number)

38-3993849

I.R.S. Employer

Identification Number

 

6607 Clara St #270, Bell Gardens, CA 90201

Phone: (502) 2082098

E-mail: manage@cannabissuissecorp.com

(Address, including zip code, and telephone number,

Including area code, of registrant’s principal executive offices)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   CSUI   OTC Markets

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days.

Yes (X) No ( )

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ( ) No (X)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer”, “emerging growth company” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

       
Large accelerated filer ( ) Accelerated filer ( )

 

Non-accelerated Filer (X) Smaller reporting company (X)
Emerging growth company ( )    

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ( ) No (X)

 

As of January 14, 2022, there were 34,091,975 shares outstanding of the registrant’s common stock.

 

 

 

 

 

 

 

 

2

 
 

 

TABLE OF CONTENTS

 

    Page

 

 

PART I

  FINANCIAL INFORMATION:  
     
Item 1. Financial Statements 4
     
  Consolidated Balance Sheets as of November 30, 2021 (unaudited) and May 31, 2021 5
     
  Consolidated Statements of Operations and Comprehensive Loss (unaudited) for the three and six months ended November 30, 2021 and 2020

 

6

     
  Consolidated Statements of Changes in Stockholders’ Deficit (unaudited) for the three and six months ended November 30, 2021 and 2020 7
     
  Consolidated Statements of Cash Flows (unaudited) for the six months ended November 30, 2021 and 2020 8
     
  Notes to the Consolidated Financial Statements (unaudited) 9
     

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and

Results of Operations

 19
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 22
     
Item 4. Controls and Procedures 22
     
PART II OTHER INFORMATION:  
     
Item 1. Legal Proceedings 23
     
Item 1A. Risk Factors 23
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
     
Item 3. Defaults Upon Senior Securities 23
     
Item 4. Mine Safety Disclosure 23
     
Item 5. Other Information 23
     
Item 6. Exhibits 24
     
   Signatures 24

 

 

 

 

3

 
 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial statements

 

The accompanying interim consolidated financial statements of Cannabis Suisse Corp. (the “Company”) should be read in conjunction with the 10-K that was filed with the United States Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, since they are interim statements, the accompanying consolidated financial statements do not include all the information and notes required by GAAP for complete financial statement presentation. In the opinion of management, the interim financial statements reflect all adjustments (consisting of normal, recurring adjustments) that are necessary for a fair presentation of the financial position, results of operations, and cash flows for the interim periods presented. Interim results are not necessarily indicative of results for a full year.

 

In the opinion of management, the consolidated financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

 

 

 

 

 

 

 

 

 

4

 

 
 

CANNABIS SUISSE CORP.

CONSOLIDATED BALANCE SHEETS

 

   

November 30,

2021

(Unaudited)

  

May 31,

2021

ASSETS        
Current Assets        
Inventory, net $ - $ 1,734
Accounts Receivable   7,770   -
Prepaid Expenses   5,962   450
Total Current Assets   13,732   2,184
Property and Equipment, net   3,220   4,383
TOTAL ASSETS $ 16,952 $ 6,567
LIABILITIES & STOCKHOLDERS’ DEFICIT        
Liabilities        
Current Liabilities        
Accrued Wages $ 173,620 $ 101,620
Advances From Related Parties   31,650   -
Convertible Notes Payable, net of debt discount   100,000   67,213
Derivative Liability   5,316   25,228
Total Current Liabilities   310,586   194,061
Total Liabilities   310,586   194,061
Commitments and Contingencies (Note 6)        
Stockholders’ Deficit        
Preferred stock, par value $0.001; 20,000,000 shares authorized, 5,000,000 and 0 shares issued and outstanding as of November 30 and May 31, 2021, respectively   5,000   -
Common stock, par value $0.001; 250,000,000 shares authorized, 31,091,975 and 34,500,000 shares issued and outstanding as of November 30 and May 31, 2021, respectively   31,092   34,500
Additional Paid-In-Capital   747,955   652,860
Accumulated Deficit   (1,077,681)   (874,854)
Total Stockholders’ Deficit   (293,634)   (187,494)
TOTAL LIABILITIES & STOCKHOLDERS’ DEFICIT $ 16,952 $ 6,567

 

 

 

The accompanying notes are an integral part of these statements.

 

 

5

 
 

 

CANNABIS SUISSE CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

 

    For the three months ended November 30, 2021   For the three months ended November 30, 2020   For the six months ended November 30, 2021   For the six months ended November 30, 2020
                 
REVENUES                
Sales of goods from principal activity $ 7,770 $ - $ 7,770 $ 36,945
Sales of goods from secondary activity   -   11,226   -   13,905
Total Revenues   7,770   11,226   7,770   50,850
Cost of goods sold   1,734   28,841   1,734   102,648
Gross (Loss) Profit   6,036   (17,615)   6,036   (51,798)
                 
OPERATING EXPENSES                
Software development costs   6,487   -   6,487   -
General and administrative expenses   36,182   59,687   73,264   163,951
Professional fees   4,136   12,000   18,386   33,896
Depreciation   582   4,163   1,164   8,324
TOTAL OPERATING EXPENSES   47,387   78,850   99,301   206,171
                 
OPERATING LOSS   (41,351)   (93,465)   (93,265)   (257,969)
                 
Interest expense, net   (17,541)   -   (62,787)   -
Change in fair value of derivative liability   1,395   -   1,841   -
Net loss on extinguishment of debt   (15,683)   -   (48,616)   -
                 
LOSS BEFORE INCOME TAXES   (73,180)   (93,465)   (202,827)   (257,969)
                 
PROVISION FOR INCOME TAXES   -   -    -   -
NET LOSS $ (73,180) $ (93,465) $ (202,827) $ (257,969)
                 
Other comprehensive (loss) income:                
Foreign currency translation adjustment   -   (8,528)   -   (8,528)
                 
COMPREHENSIVE LOSS $ (73,180) $ (101,993) $ (202,827) $ (266,497)
                 
NET LOSS PER SHARE: BASIC AND DILUTED $ (0.00) $ (0.00) $ (0.00) $ (0.00)
                 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED   31,091,975   34,500,000   31,091,975   34,500,000

 

 

 

The accompanying notes are an integral part of these statement

 

 

6

 
 

CANNABIS SUISSE CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT (UNAUDITED)

                 
  Preferred Stock Common Stock Additional Paid-In-Capital Accumulated other comprehensive loss Accumulated Deficit

Total Stockholders’

Deficit

  Shares Amount Shares Amount

Balance,

May 31, 2020

                   -                $                -                34,500,000 $   34,500 $     51,695 $        (17,221) $   (455,482) $ (386,508)
                 
Foreign currency translation adjustment - - - - - (157) - (157)
Net loss - - - - - - (164,504) (164,504)
                 

Balance,

August 31, 2020

                   -                                -                34,500,000    34,500      51,695         (17,378)    (619,986)  (551,169)
                 
Disposal of Subsidiary - - - - 511,165 17,378 - 528,543
Net loss - - - - - - (101,993) (101,993)
                 

Balance,

November 30, 2020

                   -                $                -                34,500,000    34,500 $    562,860 $                    - $   (721,979) $ (124,619)

 

 

                

Balance,

May 31, 2021

                   -                $                -                34,500,000 $   34,500 $    652,860 $                    - $   (874,854) $ (187,494)
                 
Conversion of Notes Payable into Common Shares - - 1,034,561 1 63,601 - - 64,635
Conversion of Common Shares into Preferred Shares 5,000,000 5,000 (5,000,000) (5,000) - - - -
Net loss - - - - - - (129,647) (129,647)
                 

Balance,

August 31, 2021

    5,000,000         5,000 30,534,561    30,534     716,461                     - (1,004,501)  (252,506)
                 
Conversion of Notes Payable into Common Shares - - 557,414 558 31,494 - - 32,052
Net loss - - - - - - (73,180) (73,180)
                 

Balance,

November 30, 2021

    5,000,000 $        5,000 31,091,975 $   31,092 $    747,955 $                    - $(1,077,681) $ (293,634)

 

 

The accompanying notes are an integral part of these statements.

 

 

7

 
 

 

CANNABIS SUISSE CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

 

Six months

ended

November 30, 2021

  

Six months

ended

November 30, 2020

OPERATING ACTIVITIES          
Net loss $ (202,827)   $ (266,497)
Adjustments to reconcile net loss to net cash provided by operations:          
Depreciation   1,164     8,324
Provision for Doubtful Accounts   -     78,827
Amortization Expense   -     12,772
Amortization of Debt Discount   62,787     -
Loss on Extinguishment of Debt   48,616     -
Change in Fair Value of Derivative Liability   (1,841)     -
Changes in assets and liabilities:          
Accounts Receivable   (7,770)     (1,979)
Related Party Receivables    -     8,422
VAT Tax Receivable   -     9,563
Inventory   1,734     (24,932)
Prepaid Expenses   (5,513)     (450)
Accounts Payable   -     81,507
Accrued Wages   72,000     11,375
Net cash used in Operating Activities   (31,650)     (83,068)
FINANCING ACTIVITIES          
Advances from Related Parties   31,650     62,048
Bank Indebtedness   -     21,015
Net cash provided by Financing Activities   31,650     83,063
Net cash increase (decrease) for period   -     (5)
Cash at beginning of period   -     5
Cash at end of period $ -   $ -
           
SUPPLEMENTAL          
Cash paid for taxes $ -   $ -
Cash paid for interest $ -   $ -

 

 

 

The accompanying notes are an integral part of these statements.

 

 

8

 
 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

 

The Company is engaged in the business of production of OTC (over-the-counter) products - for example CBD oils, retail branded cigarettes and also some health-related supplements. We use various distribution channels for various types of customers. The Company’s products can be sold to both corporate customers and individual clients.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company's financial position, results of operations and cash flows for the interim periods. The results of operations for the six months ended November 30, 2021 are not necessarily indicative of the results to be expected for the year ending May 31, 2022.

 

The information included in this Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended May 31, 2021.

 

Basis of presentation and consolidation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, (GAAP). The Company’s year-end is May 31. The consolidated financial statements include the accounts of the Company and its former wholly-owned subsidiary, Cannabis Suisse LLC, through the date of disposal (see Note 4). All significant inter-company accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $0 of cash and cash equivalents as of November 30, 2021 and May 31, 2021, respectively.

 

Accounts Receivable

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

 

Inventories

Inventories are stated at the lower of cost or market. The Company had $0 and $1,734 in inventory as of November 30, 2021 and May 31, 2021, respectively. The Company also determines a reserve for excess and obsolete inventory based on historical usage, and projecting the year in which inventory will be consumed into a finished product. The valuation of inventories requires management to make significant assumptions, including the assessment of market value by inventory category considering historical usage, future usage and market demand for their products, and qualitative judgments related to discontinued, slow moving and obsolete inventories. The Company had $0 in reserve for excess and obsolete inventory as of November 30, 2021 and May 31, 2021, respectively.

 

9

 
 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Property and equipment

Property and equipment are carried at cost less accumulated depreciation. Depreciation is provided over the assets’ estimated useful lives, using the straight-line method. Estimated useful lives of the plant and equipment are as follows:

 

Equipment, Furniture and fixtures 5-10 years

Office machines, IT equipment 5-10 years

Leasehold Improvements 2-5 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of operations and comprehensive loss. The cost of maintenance and repairs is charged to the consolidated statements of operations and comprehensive loss as incurred, whereas significant renewals and betterments are capitalized.

 

Impairment

The Company evaluates the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Our evaluation is based on an assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value of an asset, current or forecasted operating or cash flow losses that demonstrate continuing losses associated with the use of an asset, and a current expectation that, more likely than not, an asset will be disposed of before the end of its previously estimated useful life. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

 

During the six months ended November 30, 2021 and 2020, the Company recognized an impairment of intangibles in the amount of $0, respectively.

 

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820 Fair Value Measurements and Disclosures establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

 

These tiers include:

Level 1: defined as observable inputs such as quoted prices in active markets;
Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

 

The carrying value of the Company’s cash, other current assets, accounts payable, accrued expenses and advances from related parties approximates its fair value due to their short-term maturity. The Company has derivatives that are measured at level 3. The derivatives may require appropriate valuation adjustments that a market participant would require to arrive at fair value.

 

10

 
 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Derivatives

Derivative instruments are recognized in the Consolidated Financial Statements at fair value. Where the Company has entered into master netting agreements with counterparties, the derivative positions are netted by counterparties and are reported accordingly in other assets or other liabilities. Changes in the fair value of derivative instruments are recognized in earnings each period, unless the derivative is designated and qualifies as a cash flow or net investment hedge.

 

Income Taxes

The Company accounts for its income taxes in accordance with ASC 740, Income Taxes, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

 

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Update (ASU) 2014-09, “Revenue from contracts with customers” (Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the considerations that the Company expects to receive in exchange for those goods.

 

The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

 

The Company only applies the five-step model to contracts when it is probably that the entity will collect the consideration it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery. For our new customers, the Company generally requires orders placed to be backed by advances or deposits. In general, we provide payment terms between 30 to 60 days following receiving of goods.

 

Cost of Goods Sold

Cost of goods sold includes direct costs of selling items, direct labor cost, rent expense and electricity.

 

Basic Income (Loss) Per Share

The Company computes income (loss) per share in accordance with ASC 260 Earnings per Share. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of November 30 and May 31, 2021, there were no potentially dilutive debt or equity instruments issued or outstanding.

 

Foreign Currency Translation

Assets and liabilities of the Company’s Swiss subsidiary are translated from Swiss francs to United States dollars at exchange rates in effect at the balance sheet date. Income and expenses are translated at average exchange rates during the period. The translation adjustments for the reporting period are included in the Company’s consolidated statements of operations and comprehensive loss, and the cumulative effect of these adjustments are reported in the Company’s consolidated balance sheets as accumulated other comprehensive loss within stockholders’ deficit.

 

11

 
 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Recent Accounting Pronouncements

There have been no recent accounting pronouncements or changes in accounting pronouncements during the six months ended November 30, 2021 that are of significance or potential significance to the Company.

 

 

NOTE 3 – GOING CONCERN

 

The accompanying consolidated financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. However, the Company had limited revenues and recurring losses as of November 30, 2021. The Company has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company’s ability to continue as a going concern.

 

Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. In light of management’s efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

 

The impact of the COVID-19 pandemic has had, and is expected to continue to have, an adverse effect on our business and our financial results. COVID-19 pandemic has negatively affected global economy, disrupted consumer spending and global supply chains and created significant volatility and disruption of financial markets. The pandemic had and will continue to have an adverse effect on our business and financial performance. The extent of the impact of COVID-19, including the Company’s ability to execute its business strategies as planned, will depend on future developments, including the duration and severity of the pandemic, which are uncertain and cannot be predicted. The COVID-19 pandemic could also adversely affect its liquidity and ability to access the capital markets. Uncertainty regarding the duration of the COVID-19 pandemic may adversely impact its ability to raise additional capital, or require additional capital.

 

NOTE 4 - BUSINESS COMBINATION

 

On November 23, 2020, Cannabis Suisse Corp. (the “Transferor”), entered into an Asset Transfer Agreement with Cecillia Merige Jensen (the “Transferee”) and Cannabis Suisse LLC. In accordance with the terms of the Agreement, the Transferor transferred to the Transferee all its right, title and interest to one hundred percent (100%) of Cannabis Suisse LLC, including all its right, title and interest to one hundred percent (100%) of Grow Factory GmbH and the Transferee transferred and assigned to the Transferor 10,000,000 restricted shares of Cannabis Suisse Corp., free and clear of any and all liens and encumbrances. The above-mentioned Asset Transfer Agreement hereby revokes the effect of the Stock Transfer Agreement entered into with Cecillia Jensen on May 31, 2019, and the 10,000,000 shares were returned to the President of the Company to reinstate his ownership percentage pre-acquisition.

 

Disposal of Assets:    
Related Party Receivable $ 1,618
       Inventory   29,902
       Prepaid Taxes   12,346
Property and Equipment   71,006
VAT Tax Receivable   4,316
Operating lease right of use asset   126,881
Total Assets Transferred  $ 246,069

 

12

 

 
 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 5 – PROPERTY AND EQUIPMENT

 

Property and equipment:

  November 30, 2021   May 31, 2021
Equipment $ 16,451 $ 16,451
Leasehold Improvements   8,354   8,354
Accumulated depreciation   (21,585)   (20,422)
Net property and equipment $ 3,220 $ 4,383

 

For the three months ended November 30, 2021 and 2020 the Company recognized depreciation expense in the amount of $582 and $4,163, respectively. For the six months ended November 30, 2021 and 2020 the Company recognized depreciation expense in the amount of $1,164 and $8,324, respectively.

 

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

As of November 30, 2021 the Company has no signed agreements.

 

NOTE 7 – RELATED/THIRD PARTY TRANSACTIONS

 

The Company’s President has agreed to provide interest free advances, due on demand, to the Company up to $100,000. As of November 30 and May 31, 2021, Suneetha Nandana Silva Sudusinghe advanced to the Company $31,650 and $0, respectively.

 

NOTE 8 – CONVERTIBLE NOTES PAYABLE

 

On December 1, 2020, Suneetha Nandana Silva Sudusinghe assigned SAPA Investments, LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows SAPA Investments, LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

On December 4, 2020 Suneetha Nandana Silva Sudusinghe assigned SAPA Group, LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows SAPA Group, LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

On December 7, 2020 Suneetha Nandana Silva Sudusinghe assigned GSS Group LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows GSS Group LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

On December 10, 2020 Suneetha Nandana Silva Sudusinghe assigned Noi Tech LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Noi Tech LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

13

 

 
 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

On April 1, 2021 Suneetha Nandana Silva Sudusinghe assigned Serhii Cherniienko $60,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Serhii Cherniienko to convert the loan to common stock at a fixed price of $0.01 per share. Beneficial conversion feature was $60,000 and debt discount was $19,672.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

On April 15, 2021 Suneetha Nandana Silva Sudusinghe assigned Noi Tech LLC $30,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Noi Tech LLC to convert the loan to common stock at a fixed price of $0.01 per share. Beneficial conversion feature was $30,000 and debt discount was $7,541.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

The Company’s convertible promissory notes gave rise to derivative financial instruments. The notes embodied certain terms and conditions that were not clearly and closely related to the host debt agreement in terms of economic risks and characteristics. These terms and features consist of the embedded conversion option.

 

The following tables summarize the components of the Company’s derivative liabilities and linked common shares as of November 30, 2021 and the amounts that were reflected in income related to derivatives for the period ended:

 

    November 30, 2021  
The financings giving rise to derivative financial instruments   Indexed
Shares		     Fair
Values		  
Embedded derivatives     433,674     $  5,315  
Total     433,674     $ 5,315  

 

The following table summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the three and six months ended November 30, 2021:

 

The financings giving rise to derivative financial instruments and the gain (loss) effects:   For the Three Months Ended   For the Six Months Ended
November 30, 2021   November 30, 2021
Embedded derivatives   $                     1,395   $ 1,841
Total   $                     1,395   $ 1,841
             

Current accounting principles that are provided in ASC 815 - Derivatives and Hedging require derivative financial instruments to be classified in liabilities and carried at fair value with changes recorded in income. The Company has selected the Monte Carlo Simulation Model valuation technique to fair value the embedded derivative because it believes that this technique is reflective of all significant assumption types, and ranges of assumption inputs, that market participants would likely consider in transactions involving embedded derivatives. Such assumptions include, among other inputs, interest risk assumptions, credit risk assumptions and redemption behaviors in addition to traditional inputs for option models such as market trading volatility and risk-free rates. The Monte Carlo Simulation Model technique is a level three valuation technique because it requires the development of significant internal assumptions in addition to observable market indicators. For instruments in which the time to expiration has expired, the Company has utilized the intrinsic value as the fair value. The intrinsic value is the difference between the quoted market price on the valuation date and the applicable conversion price.

 

 

 

14

 
 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Significant inputs and results arising from the Monte Carlo Simulation process are as follows for the embedded derivatives that have been bifurcated from the convertible notes and classified in liabilities:

 

    December 1, 2020  
Quoted market price on valuation date   $0.0615  
Effective contractual conversion rates   $0.044  
Contractual term to maturity   0.25 years  
Market volatility:      
Volatility   299.09% - 479.35%  
Risk-adjusted interest rate   0.13%  

 

    December 4, 2020  
Quoted market price on valuation date   $0.0722  
Effective contractual conversion rates   $0.056  
Contractual term to maturity   0.25 years  
Market volatility:      
Volatility   239.43% - 391.85%  
Risk-adjusted interest rate   0.13%  

 

    December 7, 2020  
Quoted market price on valuation date   $0.06  
Effective contractual conversion rates   $0.0455  
Contractual term to maturity   0.25 years  
Market volatility:      
Volatility   281.02% - 381.87%  
Risk-adjusted interest rate   0.12%  

 

    December 10, 2020  
Quoted market price on valuation date   $0.0551  
Effective contractual conversion rates   $0.0419  
Contractual term to maturity   0.25 years  
Market volatility:      
Volatility   196.85% - 382.99%  
Risk-adjusted interest rate   0.12%  

 

    November 30, 2021  
Quoted market price on valuation date   $0.034  
Effective contractual conversion rates   $0.0238  
Contractual term to maturity   0.25 years  
Market volatility:      

 

Volatility   13.14% - 158.27%  
Risk-adjusted interest rate   0.08%  

 

15

 

 

 
 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

The following table reflects the issuances of embedded derivatives and changes in fair value inputs and assumptions related to the embedded derivatives as of November 30 and May 31, 2021.

 

    Period Ended   Period Ended
November 30, 2021 May 31, 2021
Balances at beginning of period   $ 25,228   $ -
Issuances:            
  Embedded derivatives     -     33,132
Conversions             (18,071)      
Changes in fair value inputs and assumptions reflected in income   (1,841)     (7,904)
             
Balances at end of period   $ 5,316   $ 25,228
             

 

NOTE 9 – REPORTABLE SEGMENTS

 

The Company follows segment reporting in accordance with ASC Topic 280, Segment Reporting. As a result of the business combination with Cannabis Suisse LLC in May 2019, the Company has changed its operating segments to consist of the Cannabis Suisse LLC segment and the Cannabis Suisse Corp segment. After the Cannabis Suisse LLC business combination, the Company's CEO began assessing performance and allocating resources based on the financial information of these two reporting segments.

 

The Cannabis Suisse LLC segment is involved in cannabis cultivation and distribution in Switzerland of recreational tobacco products and medical CBD oils. On November 23, 2020, Cannabis Suisse LLC and Cannabis Suisse Corp canceled their acquisition by Asset Transfer Agreement.

 

Cannabis Suisse Corp is engaged in the development of its business activities by conquering the USA market of CBD products since November 2020.

 

Net revenue by reporting segment for the three and six months ended November 30, 2021 and 2020, is as follows:

 

 

For the three

months ended

November 30, 2021

  

For the six

months ended

November 30, 2021

  

For the three

months ended

November 30, 2020

  

For the six

months ended

November 30, 2020

Cannabis Suisse Corp $ 7,770 $ 7,770 $ - $ -
Cannabis Suisse LLC       -       -   11,226   50,850
    Total Revenue $ 7,770 $ 7,770 $ 11,226 $ 50,850

 

Gross profit by reporting segment for the three and six months ended November 30, 2021 and 2020, is as follows:

 

For the three

months ended

November 30, 2021

  

For the six

months ended

November 30, 2021

  

For the three

months ended

November 30, 2020

  

For the six

months ended

November 30, 2020

Cannabis Suisse Corp $ 6,036 $ 6,036 $ - $ -
Cannabis Suisse LLC   -   -   (17,615)   (51,798)
    Total Gross (Loss) Profit $ 6,036 $ 6,036 $ (17,615) $ (51,798)

 

Assets by reporting segment as of November 30 and May 31, 2021, is as follows:

  November 30, 2021  

May 31,

2021

Cannabis Suisse Corp $ 16,952 $ 6,567
Cannabis Suisse LLC   -   -
    Total Assets $ 16,952 $ 6,567

 

 
 

16

 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 10 – STOCKHOLDERS’ EQUITY

 

On March 17, 2021, the Board of Directors, along with the majority stockholder, resolved that the 5,000,000 preferred shares with voting rights of 1 to 10 shall be issued to Suneetha Nandana Silva Sudusinghe in exchange for 5,000,000 common shares that Suneetha Nandana Silva Sudusinghe owned previously.

 

The 5,000,000 preferred shares were issued on July 21, 2021.

 

NOTE 11 – INCOME TAXES

 

The Company adopted the provisions of uncertain tax positions as addressed in ASC 740-10-65-1. As a result of the implementation of ASC 740-10-65-1, the Company recognized no increase in the liability for unrecognized tax benefits.

 

The Company has no tax position at November 30, 2021 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the period presented. The Company had no accruals for interest and penalties at November 30, 2021. The Company’s utilization of any net operating loss carryforward may be unlikely as a result of its intended activities.

 

The valuation allowance at November 30, 2021 was $226,313. The net change in valuation allowance for the six months ended November 30, 2021 and year ended May 31, 2021 was $42,594 and $88,068, respectively. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. 

 

Based on consideration of these items, management has determined that enough uncertainty exists relative to the realization of the deferred income tax asset balances to warrant the application of a full valuation allowance as of November 30 and May 31, 2021. All tax years since inception remains open for examination only by taxing authorities of US Federal and state of Nevada.

 

The Company has a net operating loss carryforward for tax purposes totaling $1,077,681 at November 30, 2021, expiring through fiscal year 2036. There is a limitation on the amount of taxable income that can be offset by carryforwards after a change in control (generally greater than a 50% change in ownership).

 

The components of the Company’s deferred tax asset and reconciliation of income taxes computed at the new statutory rate of 21% to the income tax amount recorded as of November 30, 2021 and May 31, 2021 are as follows:

 

    November 30, 2021   May 31, 2021
Net operating loss carryforward $ (1,077,681) $ (874,854)
Effective tax rate   21 %   21 %
Deferred tax asset   226,313   183,719
Less: Valuation allowance   (226,313)   (183,719)
Net deferred asset $ - $ -

 

17

 

 
 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

The change in the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 was $42,594 and $88,068, respectively.

 

    November 30, 2021   May 31, 2021
Federal income tax benefit attributed to:        
Net operating loss from continuing operations $ 226,313 $ 183,719
Valuation allowance   (226,313)   (183,719)
Net benefit $ - $ -

 

 

NOTE 12 – SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855), Subsequent Events the Company has analyzed its operations subsequent to November 30, 2021 to the date these consolidated financial statements were issued, and has determined that it has material subsequent events to disclose as follows:

On December 1, 2021, Suneetha Nandana Silva Sudusinghe assigned Serghei Dumanov $12,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Serghei Dumanov to convert the loan to common stock at a fixed price of $0.005 per share. The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

 

 

 

 

 

 

18

 

 
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

This quarterly report and other reports filed by Cannabis Suisse Corp. (Formerly Geant Corp.) (“we,” “us,” “our,” or the “Company”), from time to time contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the filings, the words “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

 

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

 

In General

 

Cannabis Suisse Corp. utilizes Swiss4Life as its retail brand for online selling. At this stage, Cannabis Suisse Corp. offers the following products:

 

1)Flavored Broad-Spectrum CBD Oils. The products come in one fluid ounce (30ml) bottles available in two flavors: Crème de Menthe and Cherry Vanilla. Available CBD concentrations are 1500 mg, 2500 mg and 3500 mg.

 

2)CBD Isolate Tinctures with no THC. The products come in one fluid ounce (30ml) bottles with 1000 mg CBD concentrations per bottle and 33.33 mg CBD per serving. CBD Tinctures are designed to have therapeutic effects.

 

Cannabis Suisse Corp. has initiated development of a new IT product called Cannabis Life. It is a mobile application based on an AI-chatbot that will have access to the most up-to-date information and find out data about companies and brands that sell seeds, cannabis types, etc.

 

Cannabis Life is an innovative way of searching and learning any cannabis related data. Using the most relevant sources of today, the app will keep its users up with the trends and tendencies of the cannabis industry. Communicating with the chatbot will be as smooth as it would be with a real human being thus giving users additional immersion into the learning process.

 

Research and Development Expenditures

We have not incurred any research expenditures since our incorporation.

Bankruptcy or Similar Proceedings

 

There has been no bankruptcy, receivership or similar proceeding.

 

Employees; Identification of Certain Significant Employees

 

Other than our officers and directors, we currently do not have any employees.

 

Results of Operations for the three and six months ended November 30, 2021 and 2020:

 

 

 

19

 

 
 

Revenue and Cost of Goods Sold

 

For the three months ended November 30, 2020, the Company generated total revenue of $11,226 from selling products to the customers. The cost of goods sold for the three months ended November 30, 2020 was $28,841.

 

For the three months ended November 30, 2021, the Company generated total revenue of $7,770 from selling products to the customers. The cost of goods sold for the three months ended November 30, 2021 was $1,734.

 

For the six months ended November 30, 2020, the Company generated total revenue of $50,850 from selling products to the customers. The cost of goods sold for the six months ended November 30, 2020 was $102,648.

 

For the six months ended November 30, 2021, the Company generated total revenue of $7,770 from selling products to the customers. The cost of goods sold for the six months ended November 30, 2021 was $1,734.

 

The decrease in revenues and cost of goods sold is a result of the separation of Cannabis Suisse LLC in November 2020.

 

Operating expenses

 

Total operating expenses for the three months ended November 30, 2020, were $78,850. The operating expenses for the three months ended November 30, 2020, included professional fees of $12,000; depreciation expense of $4,163; and general and administrative expenses of $59,687.

 

Total operating expenses for the three months ended November 30, 2021, were $47,387. The operating expenses for the three months ended November 30, 2021, included professional fees of $4,136; depreciation expense of $582; software development costs of $6,487 and general and administrative expenses of $36,182.

 

Total operating expenses for the six months ended November 30, 2020, were $206,171. The operating expenses for the six months ended November 30, 2020, included professional fees of $33,896; depreciation expense of $8,324; and general and administrative expenses of $163,951.

 

Total operating expenses for the six months ended November 30, 2021, were $99,301. The operating expenses for the six months ended November 30, 2021, included professional fees of $18,386; depreciation expense of $1,164; software development costs of $6,487 and general and administrative expenses of $73,264.

 

The decrease in operating expenses is related to the decrease of general and administrative expenses, and depreciation expense and professional fees due to the separation of Cannabis Suisse LLC in November 2020.

 

Changes in Fair Value of Derivatives

 

The changes in fair value of derivatives for the three months ended November 30, 2021 and 2020, was $1,395 and $0, respectively.

 

The changes in fair value of derivatives for the six months ended November 30, 2021 and 2020, was $1,841 and $0, respectively.

 

Other expenses

 

Total other expenses for the three months ended November 30, 2021 and 2020, were $33,224 and $0. The other expenses for the three months ended November 30, 2021, included interest expense of $17,541 ($0 as of November 30, 2020) and net loss on extinguishment of debt of $15,683 ($0 as of November 30, 2020).

 

Total other expenses for the six months ended November 30, 2021 and 2020, were $111,403 and $0. The other expenses for the six months ended November 30, 2021, included interest expense of $62,787 ($0 as of November 30, 2020) and net loss on extinguishment of debt of $48,616 ($0 as of November 30, 2020).

 

The increase in other expenses is related to the issuance of convertible notes in 2021.

 

 

20

 
 

 

Net Loss

 

The net loss for the three months ended November 30, 2021 and 2020, was $73,180 and $93,465, respectively.

 

The net loss for the six months ended November 30, 2021 and 2020, was $202,827 and $257,969, respectively.

 

Comprehensive Loss

 

The comprehensive loss for the three months ended November 30, 2021 and 2020 was $0 and $8,528, respectively.

 

The comprehensive loss for the six months ended November 30, 2021 and 2020 was $0 and $8,528, respectively.

 

The decrease in comprehensive loss is related to decrease in foreign currency translation adjustment after the separation of Cannabis Suisse LLC in November 2020.

 

Liquidity and Capital Resources and Cash Requirements

 

As of November 30, 2021, the Company had cash of $0. Furthermore, the Company had a working capital deficit of $296,854.

 

During the six months ended November 30, 2021 and 2020, the Company used $31,650 and $83,068 of cash in operating activities respectively. The change in cash used in operating activities is related to the decrease in net income, depreciation, accounts receivable, accrued wages, and advances from customers and the reduction in accounts payable, accrued expenses, and VAT tax receivable.

 

During the six months ended November 30, 2021 and 2020, the Company had $0 of cash in investing activities.

 

During the six months ended November 30, 2021 and 2020, the Company was provided $31,650 and $83,068 of cash in financing activities respectively, which came from advances from related, convertible debt, bank indebtedness and issue of shares.

 

In its audited consolidated financial statements as of May 31, 2021, the Company was issued a “going concern” opinion, meaning that there is substantial doubt we can continue as an on-going business for the next twelve months unless we obtain additional capital. Our only sources for cash at this time are investments by others, selling our products and loans from our director. We must raise cash to implement our plan and stay in business.

Management believes that current trends toward lower capital investment in start-up companies pose the most significant challenge to the Company’s success over the next year and in future years. Additionally, the Company will have to meet all the financial disclosure and reporting requirements associated with being a public reporting company. The Company’s management will have to spend additional time on policies and procedures to make sure it is compliant with various regulatory requirements, especially that of Section 404 of the Sarbanes-Oxley Act of 2002. This additional corporate governance time required of management could limit the amount of time management has to implement is business plan and impede the speed of its operations.

 

Limited operating history; need for additional capital

 

There is no historical financial information about us upon which to base an evaluation of our performance. We are in a start-up stage of operations and have generated limited revenues since inception. We cannot guarantee that we will be successful in our business operations. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources and possible cost overruns due to price and cost increases in services and products.

 

Off-Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

 

21

 
 

Related Party Transactions

 

There are two signed loan agreements between Cannabis Suisse Corp. and the President/CEO and a Director of the Company, Suneetha Nandana Silva Sudusinghe. The CEO agreed to loan the Loan Amount to the Company in the event of not raising a sufficient amount of funds from the offering in accordance to the Form S-1 registration statement of the Company; the director agreed to loan the Loan Amount to the Company on demand of the Company; the Company will conduct the repayments of all amounts of the Director’s loan accordingly to the sequence of loans; the director will be repaid from revenues of the Company, when it starts to earn significant revenues; advanced Loan funds are non-interest bearing, secured and payable upon demand.

 

Critical Accounting Policies

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A change in managements’ estimates or assumptions could have a material impact on our financial condition and results of operations during the period in which such changes occurred. Actual results could differ from those estimates. Our financial statements reflect all adjustments that management believes are necessary for the fair presentation of their financial condition and results of operations for the periods presented.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of November 30, 2021. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective.

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of November 30, 2021, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

 

1.We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

 

2.We did not maintain appropriate cash controls – As of November 30, 2021, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions.

 

 

 
 

 

22

 

  

 

3.We did not implement appropriate information technology controls – As of November 30, 2021, the Company retains copies of all financial data and material agreements; however, there is no formal procedure or evidence of normal backup of the Company’s data or off-site storage of data in the event of theft, misplacement, or loss due to unmitigated factors.

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of November 30, 2021, based on criteria established in Internal Control- Integrated Framework issued by COSO-2013.

 

Changes in Internal Controls over Financial Reporting

 

There has been no change in our internal control over financial reporting occurred during our third fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We know of no legal proceedings to which we are a party or to which any of our property is the subject which are pending, threatened or contemplated or any unsatisfied judgments against us.

 

Item 1A. Risk Factors

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

Item 2. Unregistered Sales Of Equity Securities And Use Of Proceeds

 

None.

 

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosure

 

Not applicable to our Company.

 

Item 5. Other Information

 

There is no other information required to be disclosed under this item which was not previously disclosed.

 

 

 

 

23

 
 

 

 

Item 6. Exhibits

 

The following exhibits are included as part of this report by reference:

 

Exhibit No.   Description
31.1    Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
     
32.1    Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized on January 14, 2022.

 

CANNABIS SUISSE CORP.
By: /s/ Suneetha Nandana Silva Sudusinghe  
  Name: Suneetha Nandana Silva Sudusinghe  
  Title: President, Treasurer and Director
    (Principal Executive, Financial and Accounting Officer)

 

 

 

 

24

 EX-31.1 2 ex31.htm

Ex.31.1


CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

 

I, Suneetha Nandana Silva Sudusinghe, certify that:

           

 

1.

 I have reviewed this Quarterly  Report Form 10-Q of CANNABIS SUISSE CORP.;
     
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
     
  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
     
  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 14, 2022

 By: /s/  Suneetha Nandana Silva Sudusinghe  
      Suneetha Nandana Silva Sudusinghe  
           

 

   

President, Treasurer, Director

(Principal Executive, Financial and Accounting Officer)

  

 

 EX-32.1 3 ex32.htm

Ex.32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with this Quarterly Report of CANNABIS SUISSE CORP., on Form 10-Q for the the quarter endedNovember 30, 2021, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Suneetha Nandana Silva Sudusinghe, Principal Executive, Financial and Accounting Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 (1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  

 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

  

     
     
Date:  January 14, 2022 By: /s/ Suneetha Nandana Silva Sudusinghe
     Suneetha Nandana Silva Sudusinghe
   

President, Treasurer, Director

(Principal Executive, Financial and Accounting Officer)

 

 EX-101.SCH 4 none-20211130.xsd 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Changes in Stockholders Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - BUSINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - ROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - RELATED/THIRD PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - REPORTABLE SEGMENTS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - ROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Property and equipment: (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 none-20211130_cal.xml EX-101.DEF 6 none-20211130_def.xml EX-101.LAB 7 none-20211130_lab.xml Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Cover [Abstract] DocumentType Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report DocumentTransitionReport Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date File Number Registrant Name Entity Central Index Key Entity Primary SIC Number TaxIdentificationNumber IncorporationStateCountryCode AddressLine1 Entity Address, Address Line Two Entity Address, Address Line Three AddressCityOrTown Address State Entity Address, Country AddressPostalZipCode Country Region CityAreaCode LocalPhoneNumber Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Current Reporting Status Interactive Data Current Filer Category SmallBusiness Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current CommonStockSharesOutstanding Documents Incorporated by Reference [Text Block] ContactPersonnelEmailAddress Statement of Financial Position [Abstract] ASSETS Current Assets Inventory, net Accounts Receivable Prepaid Expenses Total Current Assets Property and Equipment, net TOTAL ASSETS LIABILITIES & STOCKHOLDERS’ DEFICIT Liabilities Current Liabilities Accrued Wages Advances From Related Parties Convertible Notes Payable, net of debt discount Derivative Liability Total Current Liabilities Total Liabilities Commitments and Contingencies (Note 6) Stockholders’ Deficit Preferred stock, par value $0.001; 20,000,000 shares authorized, 5,000,000 and 0 shares issued and outstanding as of November 30 and May 31, 2021, respectively Common stock, par value $0.001; 250,000,000 shares authorized, 31,091,975 and 34,500,000 shares issued and outstanding as of November 30 and May 31, 2021, respectively Additional Paid-In-Capital Accumulated Deficit Total Stockholders’ Deficit TOTAL LIABILITIES & STOCKHOLDERS’ DEFICIT PreferredStockParOrStatedValuePerShare PreferredStockSharesAuthorized PreferredStockSharesOutstanding PreferredStockSharesIssued CommonStockParOrStatedValuePerShare CommonStockSharesAuthorized CommonStock SharesIssued CommonStock SharesOutstanding Income Statement [Abstract] REVENUES Sales of goods from principal activity Sales of goods from secondary activity Total Revenues Cost of goods sold Gross (Loss) Profit OPERATING EXPENSES Software development costs General and administrative expenses Professional fees Depreciation TOTAL OPERATING EXPENSES OPERATING LOSS Interest expense, net Change in fair value of derivative liability Net loss on extinguishment of debt LOSS BEFORE INCOME TAXES PROVISION FOR INCOME TAXES NET LOSS Other comprehensive (loss) income: Foreign currency translation adjustment COMPREHENSIVE LOSS NET LOSS PER SHARE: BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Foreign currency translation adjustment Net loss Ending balance, value Balance, November, 2020 Beginning balance, value Beginning balance, value Conversion of Notes Payable into Common Shares Conversion of Notes Payable, Common Shares Conversion of Common Shares into Preferred Shares Conversion of Common Shares into Preferred Shares Preferred Stock on August 31,2021 Conversion of Notes Payable into Common Shares Net loss Ending balance, value Preferred Shares Ending balance, shares Ending balance, shares Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash provided by operations: Depreciation Provision for Doubtful Accounts Amortization Expense Amortization of Debt Discount Loss on Extinguishment of Debt Change in Fair Value of Derivative Liability Changes in assets and liabilities: Accounts Receivable Related Party Receivables VAT Tax Receivable Inventory Prepaid Expenses Accounts Payable Accrued Wages Net cash used in Operating Activities FINANCING ACTIVITIES Advances from Related Parties Bank Indebtedness Net cash provided by Financing Activities Net cash increase (decrease) for period Cash at beginning of period Cash at end of period SUPPLEMENTAL Cash paid for taxes Cash paid for interest Accounting Policies [Abstract] ORGANIZATION AND NATURE OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] GOING CONCERN BUSINESS COMBINATION ROPERTY AND EQUIPMENT COMMITMENTS AND CONTINGENCIES Related Party Transactions [Abstract] RELATED/THIRD PARTY TRANSACTIONS Debt Disclosure [Abstract] CONVERTIBLE NOTES PAYABLE Segment Reporting [Abstract] REPORTABLE SEGMENTS Equity [Abstract] STOCKHOLDERS’ EQUITY INCOME TAXES SUBSEQUENT EVENTS Basis of presentation and consolidation Use of Estimates Cash Accounts Receivable nventories Property and equipment Impairment Fair Value of Financial Instruments Derivatives Taxes Revenue Recognition Cost of Goods Sold asic Income (Loss) Per Share Foreign Currency Translation Recent Accounting Pronouncements Property and equipment: the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 Equipment Leasehold Improvements Accumulated depreciation Net property and equipment Net operating loss carryforward Deferred tax asset Less: Valuation allowance Net deferred asset Federal income tax benefit attributed to: Net operating loss from continuing operations Valuation allowance Assets, Current Assets Liabilities, Current Liabilities [Default Label] Stockholders' Equity Note, Subscriptions Receivable Liabilities and Equity Revenues Gross Profit Operating Expenses Operating Income (Loss) Interest Income (Expense), Nonoperating, Net Extinguishment of Debt, Gain (Loss), Per Share, Net of Tax Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Stockholders' Equity Attributable to Parent Common Stock, Other Shares, Outstanding Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Common Stock, Other Value, Outstanding Debt Instrument, Convertible, Type of Equity Security Debt Instrument, Convertible, Conversion Price, Increase Net Income (Loss) Available to Common Stockholders, Basic Net Investment Income Depreciation [Default Label] Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accrued Salaries Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash, Period Increase (Decrease), Excluding Exchange Rate Effect Cash [Default Label] Cash Equivalents, at Carrying Value Accounts and Nontrade Receivable [Text Block] Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Operating Loss Carryforwards Operating Loss Carryforwards, Valuation Allowance EX-101.PRE 8 none-20211130_pre.xml XML 9 R1.htm IDEA: XBRL DOCUMENT v3.21.4
Cover - shares
 6 Months Ended
Nov. 30, 2021
Jan. 14, 2022
Cover [Abstract]    
DocumentType 10-Q  
Amendment Flag false  
Document Quarterly Report true  
DocumentTransitionReport false  
Document Period End Date Nov. 30, 2021  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --05-31  
File Number 333-213009  
Registrant Name CANNABIS SUISSE CORP.  
Entity Central Index Key 0001680132  
TaxIdentificationNumber 38-3993849  
IncorporationStateCountryCode NV  
AddressLine1 6607 Clara St #270  
AddressCityOrTown Bell Gardens  
Address State CA  
AddressPostalZipCode 90201  
CityAreaCode 502  
LocalPhoneNumber 2082098  
Current Reporting Status Yes  
Interactive Data Current No  
Filer Category Non-accelerated Filer  
SmallBusiness true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Shell Company false  
CommonStockSharesOutstanding   34,091,975
ContactPersonnelEmailAddress manage@cannabissuissecorp.com  
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.21.4
BALANCE SHEETS - USD ($)
Nov. 30, 2021
May 31, 2021
Current Assets    
Inventory, net $ 1,734
Accounts Receivable 7,770
Prepaid Expenses 5,962 450
Total Current Assets 13,732 2,184
Property and Equipment, net 3,220 4,383
TOTAL ASSETS 16,952 6,567
Current Liabilities    
Accrued Wages 173,620 101,620
Advances From Related Parties 31,650
Convertible Notes Payable, net of debt discount 100,000 67,213
Derivative Liability 5,316 25,228
Total Current Liabilities 310,586 194,061
Total Liabilities 310,586 194,061
Stockholders’ Deficit    
Preferred stock, par value $0.001; 20,000,000 shares authorized, 5,000,000 and 0 shares issued and outstanding as of November 30 and May 31, 2021, respectively 5,000
Common stock, par value $0.001; 250,000,000 shares authorized, 31,091,975 and 34,500,000 shares issued and outstanding as of November 30 and May 31, 2021, respectively 31,092 34,500
Additional Paid-In-Capital 747,955 652,860
Accumulated Deficit (1,077,681) (874,854)
Total Stockholders’ Deficit (293,634) (187,494)
TOTAL LIABILITIES & STOCKHOLDERS’ DEFICIT $ 16,952 $ 6,567
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.21.4
BALANCE SHEETS (Parenthetical) - $ / shares
Nov. 30, 2021
May 31, 2021
Statement of Financial Position [Abstract]    
PreferredStockParOrStatedValuePerShare $ 0.001 $ 0.001
PreferredStockSharesAuthorized 20,000,000 20,000,000
PreferredStockSharesOutstanding 5,000,000 0
PreferredStockSharesIssued 5,000,000 0
CommonStockParOrStatedValuePerShare $ 0.001 $ 0.001
CommonStockSharesAuthorized 250,000,000 250,000,000
CommonStock SharesIssued 31,091,975 34,500,000
CommonStock SharesOutstanding 31,091,975 34,500,000
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.21.4
STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 6 Months Ended
Nov. 30, 2021
Nov. 30, 2020
Nov. 30, 2021
Nov. 30, 2020
REVENUES        
Sales of goods from principal activity $ 7,770 $ 7,770 $ 36,945
Sales of goods from secondary activity - 11,226 - 13,905
Total Revenues $ 7,770 $ 11,226 $ 7,770 $ 50,850
Cost of goods sold 1,734 28,841 1,734 102,648
Gross (Loss) Profit 6,036 (17,615) 6,036 (51,798)
OPERATING EXPENSES        
Software development costs 6,487 6,487
General and administrative expenses 36,182 59,687 73,264 163,951
Professional fees 4,136 12,000 18,386 33,896
Depreciation 582 4,163 1,164 8,324
TOTAL OPERATING EXPENSES 47,387 78,850 99,301 206,171
OPERATING LOSS (41,351) (93,465) (93,265) (257,969)
Interest expense, net (17,541) (62,787)
Change in fair value of derivative liability $ 1,395 $ 1,841
Net loss on extinguishment of debt $ (15,683) $ (48,616)
LOSS BEFORE INCOME TAXES $ (73,180) $ (93,465) $ (202,827) $ (257,969)
PROVISION FOR INCOME TAXES
NET LOSS (73,180) (93,465) (202,827) (257,969)
Other comprehensive (loss) income:        
Foreign currency translation adjustment (8,528) (8,528)
COMPREHENSIVE LOSS $ (73,180) $ (101,993) $ (202,827) $ (266,497)
NET LOSS PER SHARE: BASIC AND DILUTED $ (0.00) $ (0.00) $ (0.00) $ (0.00)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED 31,091,975 34,500,000 31,091,975 34,500,000
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.21.4
Statements of Changes in Stockholders Equity - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at May. 31, 2020 $ 34,500 $ 51,695 $ (17,221) $ (455,482) $ (386,508)
Beginning balance, shares at May. 31, 2020           34,500,000
Foreign currency translation adjustment (157) $ (157)
Net loss (164,504) (164,504)
Ending balance, value at Aug. 31, 2020 34,500 51,695 (17,378) (619,986) $ (551,169)
Balance, November, 2020 at Aug. 31, 2020           34,500,000
Net loss (101,993) $ (101,993)
Ending balance, value at Nov. 30, 2020 34,500 562,860 (721,979) $ (124,619)
Balance, November, 2020 at Nov. 30, 2020           34,500,000
Net loss (129,647) $ (129,647)
Beginning balance, value at May. 31, 2021 34,500 652,860 (874,854) (187,494)
Beginning balance, value at May. 31, 2021           34,500,000
Conversion of Notes Payable into Common Shares $ 1 $ 63,601 $ 64,635
Conversion of Notes Payable, Common Shares           $ 1,034,561
Conversion of Common Shares into Preferred Shares 5,000 (5,000)
Conversion of Common Shares into Preferred Shares           5,000,000
Preferred Stock on August 31,2021 at May. 31, 2021           0
Ending balance, value at Aug. 31, 2021 $ 5,000 $ 30,534 $ 716,461 $ (1,004,501) $ (252,506)
Preferred Shares Ending balance, shares at Aug. 31, 2021           5,000,000
Beginning balance, value at Aug. 31, 2021           $ 30,534,561
Conversion of Notes Payable, Common Shares           $ 557,414
Conversion of Notes Payable into Common Shares $ 558 $ 31,494 $ 32,052
Net loss $ (73,180) $ (73,180)
Ending balance, value at Nov. 30, 2021 $ 5,000 $ 31,092 $ 747,955 $ (1,077,681) $ (293,634)
Preferred Shares Ending balance, shares at Nov. 30, 2021           5,000,000
Ending balance, shares at Nov. 30, 2021           31,091,975
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.21.4
STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Nov. 30, 2021
Nov. 30, 2020
OPERATING ACTIVITIES    
Net loss $ (202,827) $ (266,497)
Adjustments to reconcile net loss to net cash provided by operations:    
Depreciation 1,164 8,324
Provision for Doubtful Accounts 78,827
Amortization Expense 12,772
Amortization of Debt Discount 62,787
Loss on Extinguishment of Debt 48,616
Change in Fair Value of Derivative Liability (1,841)
Changes in assets and liabilities:    
Accounts Receivable (7,770) (1,979)
Related Party Receivables 8,422
VAT Tax Receivable 9,563
Inventory 1,734 (24,932)
Prepaid Expenses (5,513) (450)
Accounts Payable 81,507
Accrued Wages 72,000 11,375
Net cash used in Operating Activities (31,650) (83,068)
FINANCING ACTIVITIES    
Advances from Related Parties 31,650 62,048
Bank Indebtedness 21,015
Net cash provided by Financing Activities 31,650 83,063
Net cash increase (decrease) for period (5)
Cash at beginning of period 5
Cash at end of period
SUPPLEMENTAL    
Cash paid for taxes
Cash paid for interest
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.21.4
ORGANIZATION AND NATURE OF BUSINESS
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
ORGANIZATION AND NATURE OF BUSINESS

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

 

The Company is engaged in the business of production of OTC (over-the-counter) products - for example CBD oils, retail branded cigarettes and also some health-related supplements. We use various distribution channels for various types of customers. The Company’s products can be sold to both corporate customers and individual clients.

 
XML 16 R8.htm IDEA: XBRL DOCUMENT v3.21.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company's financial position, results of operations and cash flows for the interim periods. The results of operations for the six months ended November 30, 2021 are not necessarily indicative of the results to be expected for the year ending May 31, 2022.

 

The information included in this Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended May 31, 2021.

 

Basis of presentation and consolidation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, (GAAP). The Company’s year-end is May 31. The consolidated financial statements include the accounts of the Company and its former wholly-owned subsidiary, Cannabis Suisse LLC, through the date of disposal (see Note 4). All significant inter-company accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $0 of cash and cash equivalents as of November 30, 2021 and May 31, 2021, respectively.

 

Accounts Receivable

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

 

Inventories

Inventories are stated at the lower of cost or market. The Company had $0 and $1,734 in inventory as of November 30, 2021 and May 31, 2021, respectively. The Company also determines a reserve for excess and obsolete inventory based on historical usage, and projecting the year in which inventory will be consumed into a finished product. The valuation of inventories requires management to make significant assumptions, including the assessment of market value by inventory category considering historical usage, future usage and market demand for their products, and qualitative judgments related to discontinued, slow moving and obsolete inventories. The Company had $0 in reserve for excess and obsolete inventory as of November 30, 2021 and May 31, 2021, respectively.

 

9

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Property and equipment

Property and equipment are carried at cost less accumulated depreciation. Depreciation is provided over the assets’ estimated useful lives, using the straight-line method. Estimated useful lives of the plant and equipment are as follows:

 

Equipment, Furniture and fixtures 5-10 years

Office machines, IT equipment 5-10 years

Leasehold Improvements 2-5 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of operations and comprehensive loss. The cost of maintenance and repairs is charged to the consolidated statements of operations and comprehensive loss as incurred, whereas significant renewals and betterments are capitalized.

 

Impairment

The Company evaluates the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Our evaluation is based on an assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value of an asset, current or forecasted operating or cash flow losses that demonstrate continuing losses associated with the use of an asset, and a current expectation that, more likely than not, an asset will be disposed of before the end of its previously estimated useful life. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

 

During the six months ended November 30, 2021 and 2020, the Company recognized an impairment of intangibles in the amount of $0, respectively.

 

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820 Fair Value Measurements and Disclosures establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

 

These tiers include:

Level 1: defined as observable inputs such as quoted prices in active markets;
Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

 

The carrying value of the Company’s cash, other current assets, accounts payable, accrued expenses and advances from related parties approximates its fair value due to their short-term maturity. The Company has derivatives that are measured at level 3. The derivatives may require appropriate valuation adjustments that a market participant would require to arrive at fair value.

 

10

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Derivatives

Derivative instruments are recognized in the Consolidated Financial Statements at fair value. Where the Company has entered into master netting agreements with counterparties, the derivative positions are netted by counterparties and are reported accordingly in other assets or other liabilities. Changes in the fair value of derivative instruments are recognized in earnings each period, unless the derivative is designated and qualifies as a cash flow or net investment hedge.

 

Income Taxes

The Company accounts for its income taxes in accordance with ASC 740, Income Taxes, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

 

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Update (ASU) 2014-09, “Revenue from contracts with customers” (Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the considerations that the Company expects to receive in exchange for those goods.

 

The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

 

The Company only applies the five-step model to contracts when it is probably that the entity will collect the consideration it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery. For our new customers, the Company generally requires orders placed to be backed by advances or deposits. In general, we provide payment terms between 30 to 60 days following receiving of goods.

 

Cost of Goods Sold

Cost of goods sold includes direct costs of selling items, direct labor cost, rent expense and electricity.

 

Basic Income (Loss) Per Share

The Company computes income (loss) per share in accordance with ASC 260 Earnings per Share. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of November 30 and May 31, 2021, there were no potentially dilutive debt or equity instruments issued or outstanding.

 

Foreign Currency Translation

Assets and liabilities of the Company’s Swiss subsidiary are translated from Swiss francs to United States dollars at exchange rates in effect at the balance sheet date. Income and expenses are translated at average exchange rates during the period. The translation adjustments for the reporting period are included in the Company’s consolidated statements of operations and comprehensive loss, and the cumulative effect of these adjustments are reported in the Company’s consolidated balance sheets as accumulated other comprehensive loss within stockholders’ deficit.

 

11

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Recent Accounting Pronouncements

There have been no recent accounting pronouncements or changes in accounting pronouncements during the six months ended November 30, 2021 that are of significance or potential significance to the Company.

 

 
XML 17 R9.htm IDEA: XBRL DOCUMENT v3.21.4
GOING CONCERN
 6 Months Ended
Nov. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 3 – GOING CONCERN

 

The accompanying consolidated financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. However, the Company had limited revenues and recurring losses as of November 30, 2021. The Company has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company’s ability to continue as a going concern.

 

Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. In light of management’s efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

 

The impact of the COVID-19 pandemic has had, and is expected to continue to have, an adverse effect on our business and our financial results. COVID-19 pandemic has negatively affected global economy, disrupted consumer spending and global supply chains and created significant volatility and disruption of financial markets. The pandemic had and will continue to have an adverse effect on our business and financial performance. The extent of the impact of COVID-19, including the Company’s ability to execute its business strategies as planned, will depend on future developments, including the duration and severity of the pandemic, which are uncertain and cannot be predicted. The COVID-19 pandemic could also adversely affect its liquidity and ability to access the capital markets. Uncertainty regarding the duration of the COVID-19 pandemic may adversely impact its ability to raise additional capital, or require additional capital.

 
XML 18 R10.htm IDEA: XBRL DOCUMENT v3.21.4
BUSINESS COMBINATION
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
BUSINESS COMBINATION

NOTE 4 - BUSINESS COMBINATION

 

On November 23, 2020, Cannabis Suisse Corp. (the “Transferor”), entered into an Asset Transfer Agreement with Cecillia Merige Jensen (the “Transferee”) and Cannabis Suisse LLC. In accordance with the terms of the Agreement, the Transferor transferred to the Transferee all its right, title and interest to one hundred percent (100%) of Cannabis Suisse LLC, including all its right, title and interest to one hundred percent (100%) of Grow Factory GmbH and the Transferee transferred and assigned to the Transferor 10,000,000 restricted shares of Cannabis Suisse Corp., free and clear of any and all liens and encumbrances. The above-mentioned Asset Transfer Agreement hereby revokes the effect of the Stock Transfer Agreement entered into with Cecillia Jensen on May 31, 2019, and the 10,000,000 shares were returned to the President of the Company to reinstate his ownership percentage pre-acquisition.

 

Disposal of Assets:    
Related Party Receivable $ 1,618
       Inventory   29,902
       Prepaid Taxes   12,346
Property and Equipment   71,006
VAT Tax Receivable   4,316
Operating lease right of use asset   126,881
Total Assets Transferred  $ 246,069

 

12

 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 
XML 19 R11.htm IDEA: XBRL DOCUMENT v3.21.4
ROPERTY AND EQUIPMENT
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
ROPERTY AND EQUIPMENT

NOTE 5 – PROPERTY AND EQUIPMENT

 

Property and equipment:

  November 30, 2021   May 31, 2021
Equipment $ 16,451 $ 16,451
Leasehold Improvements   8,354   8,354
Accumulated depreciation   (21,585)   (20,422)
Net property and equipment $ 3,220 $ 4,383

 

For the three months ended November 30, 2021 and 2020 the Company recognized depreciation expense in the amount of $582 and $4,163, respectively. For the six months ended November 30, 2021 and 2020 the Company recognized depreciation expense in the amount of $1,164 and $8,324, respectively.

 
XML 20 R12.htm IDEA: XBRL DOCUMENT v3.21.4
COMMITMENTS AND CONTINGENCIES
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

As of November 30, 2021 the Company has no signed agreements.

 
XML 21 R13.htm IDEA: XBRL DOCUMENT v3.21.4
RELATED/THIRD PARTY TRANSACTIONS
 6 Months Ended
Nov. 30, 2021
Related Party Transactions [Abstract]  
RELATED/THIRD PARTY TRANSACTIONS

NOTE 7 – RELATED/THIRD PARTY TRANSACTIONS

 

The Company’s President has agreed to provide interest free advances, due on demand, to the Company up to $100,000. As of November 30 and May 31, 2021, Suneetha Nandana Silva Sudusinghe advanced to the Company $31,650 and $0, respectively.

 
XML 22 R14.htm IDEA: XBRL DOCUMENT v3.21.4
CONVERTIBLE NOTES PAYABLE
 6 Months Ended
Nov. 30, 2021
Debt Disclosure [Abstract]  
CONVERTIBLE NOTES PAYABLE

NOTE 8 – CONVERTIBLE NOTES PAYABLE

 

On December 1, 2020, Suneetha Nandana Silva Sudusinghe assigned SAPA Investments, LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows SAPA Investments, LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

On December 4, 2020 Suneetha Nandana Silva Sudusinghe assigned SAPA Group, LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows SAPA Group, LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

On December 7, 2020 Suneetha Nandana Silva Sudusinghe assigned GSS Group LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows GSS Group LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

On December 10, 2020 Suneetha Nandana Silva Sudusinghe assigned Noi Tech LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Noi Tech LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

13

 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

On April 1, 2021 Suneetha Nandana Silva Sudusinghe assigned Serhii Cherniienko $60,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Serhii Cherniienko to convert the loan to common stock at a fixed price of $0.01 per share. Beneficial conversion feature was $60,000 and debt discount was $19,672.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

On April 15, 2021 Suneetha Nandana Silva Sudusinghe assigned Noi Tech LLC $30,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Noi Tech LLC to convert the loan to common stock at a fixed price of $0.01 per share. Beneficial conversion feature was $30,000 and debt discount was $7,541.

 

The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.

 

The Company’s convertible promissory notes gave rise to derivative financial instruments. The notes embodied certain terms and conditions that were not clearly and closely related to the host debt agreement in terms of economic risks and characteristics. These terms and features consist of the embedded conversion option.

 

The following tables summarize the components of the Company’s derivative liabilities and linked common shares as of November 30, 2021 and the amounts that were reflected in income related to derivatives for the period ended:

 

    November 30, 2021  
The financings giving rise to derivative financial instruments   Indexed
Shares		     Fair
Values		  
Embedded derivatives     433,674     $  5,315  
Total     433,674     $ 5,315  

 

The following table summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the three and six months ended November 30, 2021:

 

The financings giving rise to derivative financial instruments and the gain (loss) effects:   For the Three Months Ended   For the Six Months Ended
November 30, 2021   November 30, 2021
Embedded derivatives   $                     1,395   $ 1,841
Total   $                     1,395   $ 1,841
             

Current accounting principles that are provided in ASC 815 - Derivatives and Hedging require derivative financial instruments to be classified in liabilities and carried at fair value with changes recorded in income. The Company has selected the Monte Carlo Simulation Model valuation technique to fair value the embedded derivative because it believes that this technique is reflective of all significant assumption types, and ranges of assumption inputs, that market participants would likely consider in transactions involving embedded derivatives. Such assumptions include, among other inputs, interest risk assumptions, credit risk assumptions and redemption behaviors in addition to traditional inputs for option models such as market trading volatility and risk-free rates. The Monte Carlo Simulation Model technique is a level three valuation technique because it requires the development of significant internal assumptions in addition to observable market indicators. For instruments in which the time to expiration has expired, the Company has utilized the intrinsic value as the fair value. The intrinsic value is the difference between the quoted market price on the valuation date and the applicable conversion price.

 

 

 

14

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Significant inputs and results arising from the Monte Carlo Simulation process are as follows for the embedded derivatives that have been bifurcated from the convertible notes and classified in liabilities:

 

    December 1, 2020  
Quoted market price on valuation date   $0.0615  
Effective contractual conversion rates   $0.044  
Contractual term to maturity   0.25 years  
Market volatility:      
Volatility   299.09% - 479.35%  
Risk-adjusted interest rate   0.13%  

 

    December 4, 2020  
Quoted market price on valuation date   $0.0722  
Effective contractual conversion rates   $0.056  
Contractual term to maturity   0.25 years  
Market volatility:      
Volatility   239.43% - 391.85%  
Risk-adjusted interest rate   0.13%  

 

    December 7, 2020  
Quoted market price on valuation date   $0.06  
Effective contractual conversion rates   $0.0455  
Contractual term to maturity   0.25 years  
Market volatility:      
Volatility   281.02% - 381.87%  
Risk-adjusted interest rate   0.12%  

 

    December 10, 2020  
Quoted market price on valuation date   $0.0551  
Effective contractual conversion rates   $0.0419  
Contractual term to maturity   0.25 years  
Market volatility:      
Volatility   196.85% - 382.99%  
Risk-adjusted interest rate   0.12%  

 

    November 30, 2021  
Quoted market price on valuation date   $0.034  
Effective contractual conversion rates   $0.0238  
Contractual term to maturity   0.25 years  
Market volatility:      

 

Volatility   13.14% - 158.27%  
Risk-adjusted interest rate   0.08%  

 

15

 

 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

The following table reflects the issuances of embedded derivatives and changes in fair value inputs and assumptions related to the embedded derivatives as of November 30 and May 31, 2021.

 

    Period Ended   Period Ended
November 30, 2021 May 31, 2021
Balances at beginning of period   $ 25,228   $ -
Issuances:            
  Embedded derivatives     -     33,132
Conversions             (18,071)      
Changes in fair value inputs and assumptions reflected in income   (1,841)     (7,904)
             
Balances at end of period   $ 5,316   $ 25,228
             

 
XML 23 R15.htm IDEA: XBRL DOCUMENT v3.21.4
REPORTABLE SEGMENTS
 6 Months Ended
Nov. 30, 2021
Segment Reporting [Abstract]  
REPORTABLE SEGMENTS

NOTE 9 – REPORTABLE SEGMENTS

 

The Company follows segment reporting in accordance with ASC Topic 280, Segment Reporting. As a result of the business combination with Cannabis Suisse LLC in May 2019, the Company has changed its operating segments to consist of the Cannabis Suisse LLC segment and the Cannabis Suisse Corp segment. After the Cannabis Suisse LLC business combination, the Company's CEO began assessing performance and allocating resources based on the financial information of these two reporting segments.

 

The Cannabis Suisse LLC segment is involved in cannabis cultivation and distribution in Switzerland of recreational tobacco products and medical CBD oils. On November 23, 2020, Cannabis Suisse LLC and Cannabis Suisse Corp canceled their acquisition by Asset Transfer Agreement.

 

Cannabis Suisse Corp is engaged in the development of its business activities by conquering the USA market of CBD products since November 2020.

 

Net revenue by reporting segment for the three and six months ended November 30, 2021 and 2020, is as follows:

 

 

For the three

months ended

November 30, 2021

  

For the six

months ended

November 30, 2021

  

For the three

months ended

November 30, 2020

  

For the six

months ended

November 30, 2020

Cannabis Suisse Corp $ 7,770 $ 7,770 $ - $ -
Cannabis Suisse LLC       -       -   11,226   50,850
    Total Revenue $ 7,770 $ 7,770 $ 11,226 $ 50,850

 

Gross profit by reporting segment for the three and six months ended November 30, 2021 and 2020, is as follows:

 

For the three

months ended

November 30, 2021

  

For the six

months ended

November 30, 2021

  

For the three

months ended

November 30, 2020

  

For the six

months ended

November 30, 2020

Cannabis Suisse Corp $ 6,036 $ 6,036 $ - $ -
Cannabis Suisse LLC   -   -   (17,615)   (51,798)
    Total Gross (Loss) Profit $ 6,036 $ 6,036 $ (17,615) $ (51,798)

 

Assets by reporting segment as of November 30 and May 31, 2021, is as follows:

  November 30, 2021  

May 31,

2021

Cannabis Suisse Corp $ 16,952 $ 6,567
Cannabis Suisse LLC   -   -
    Total Assets $ 16,952 $ 6,567

 

16

 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 
XML 24 R16.htm IDEA: XBRL DOCUMENT v3.21.4
STOCKHOLDERS’ EQUITY
 6 Months Ended
Nov. 30, 2021
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 10 – STOCKHOLDERS’ EQUITY

 

On March 17, 2021, the Board of Directors, along with the majority stockholder, resolved that the 5,000,000 preferred shares with voting rights of 1 to 10 shall be issued to Suneetha Nandana Silva Sudusinghe in exchange for 5,000,000 common shares that Suneetha Nandana Silva Sudusinghe owned previously.

 

The 5,000,000 preferred shares were issued on July 21, 2021.

 
XML 25 R17.htm IDEA: XBRL DOCUMENT v3.21.4
INCOME TAXES
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
INCOME TAXES

NOTE 11 – INCOME TAXES

 

The Company adopted the provisions of uncertain tax positions as addressed in ASC 740-10-65-1. As a result of the implementation of ASC 740-10-65-1, the Company recognized no increase in the liability for unrecognized tax benefits.

 

The Company has no tax position at November 30, 2021 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the period presented. The Company had no accruals for interest and penalties at November 30, 2021. The Company’s utilization of any net operating loss carryforward may be unlikely as a result of its intended activities.

 

The valuation allowance at November 30, 2021 was $226,313. The net change in valuation allowance for the six months ended November 30, 2021 and year ended May 31, 2021 was $42,594 and $88,068, respectively. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. 

 

Based on consideration of these items, management has determined that enough uncertainty exists relative to the realization of the deferred income tax asset balances to warrant the application of a full valuation allowance as of November 30 and May 31, 2021. All tax years since inception remains open for examination only by taxing authorities of US Federal and state of Nevada.

 

The Company has a net operating loss carryforward for tax purposes totaling $1,077,681 at November 30, 2021, expiring through fiscal year 2036. There is a limitation on the amount of taxable income that can be offset by carryforwards after a change in control (generally greater than a 50% change in ownership).

 

The components of the Company’s deferred tax asset and reconciliation of income taxes computed at the new statutory rate of 21% to the income tax amount recorded as of November 30, 2021 and May 31, 2021 are as follows:

 

    November 30, 2021   May 31, 2021
Net operating loss carryforward $ (1,077,681) $ (874,854)
Effective tax rate   21 %   21 %
Deferred tax asset   226,313   183,719
Less: Valuation allowance   (226,313)   (183,719)
Net deferred asset $ - $ -

 

17

 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

The change in the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 was $42,594 and $88,068, respectively.

 

    November 30, 2021   May 31, 2021
Federal income tax benefit attributed to:        
Net operating loss from continuing operations $ 226,313 $ 183,719
Valuation allowance   (226,313)   (183,719)
Net benefit $ - $ -

 

 
XML 26 R18.htm IDEA: XBRL DOCUMENT v3.21.4
SUBSEQUENT EVENTS
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
SUBSEQUENT EVENTS

NOTE 12 – SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855), Subsequent Events the Company has analyzed its operations subsequent to November 30, 2021 to the date these consolidated financial statements were issued, and has determined that it has material subsequent events to disclose as follows:

On December 1, 2021, Suneetha Nandana Silva Sudusinghe assigned Serghei Dumanov $12,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Serghei Dumanov to convert the loan to common stock at a fixed price of $0.005 per share. The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.
XML 27 R19.htm IDEA: XBRL DOCUMENT v3.21.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
Basis of presentation and consolidation

Basis of presentation and consolidation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, (GAAP). The Company’s year-end is May 31. The consolidated financial statements include the accounts of the Company and its former wholly-owned subsidiary, Cannabis Suisse LLC, through the date of disposal (see Note 4). All significant inter-company accounts and transactions have been eliminated in consolidation.

 
Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 
Cash

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $0 of cash and cash equivalents as of November 30, 2021 and May 31, 2021, respectively.

 
Accounts Receivable

Accounts Receivable

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

 
nventories

Inventories

Inventories are stated at the lower of cost or market. The Company had $0 and $1,734 in inventory as of November 30, 2021 and May 31, 2021, respectively. The Company also determines a reserve for excess and obsolete inventory based on historical usage, and projecting the year in which inventory will be consumed into a finished product. The valuation of inventories requires management to make significant assumptions, including the assessment of market value by inventory category considering historical usage, future usage and market demand for their products, and qualitative judgments related to discontinued, slow moving and obsolete inventories. The Company had $0 in reserve for excess and obsolete inventory as of November 30, 2021 and May 31, 2021, respectively.

 

9

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 
Property and equipment

Property and equipment

Property and equipment are carried at cost less accumulated depreciation. Depreciation is provided over the assets’ estimated useful lives, using the straight-line method. Estimated useful lives of the plant and equipment are as follows:

 

Equipment, Furniture and fixtures 5-10 years

Office machines, IT equipment 5-10 years

Leasehold Improvements 2-5 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of operations and comprehensive loss. The cost of maintenance and repairs is charged to the consolidated statements of operations and comprehensive loss as incurred, whereas significant renewals and betterments are capitalized.

 
Impairment

Impairment

The Company evaluates the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Our evaluation is based on an assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value of an asset, current or forecasted operating or cash flow losses that demonstrate continuing losses associated with the use of an asset, and a current expectation that, more likely than not, an asset will be disposed of before the end of its previously estimated useful life. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

 

During the six months ended November 30, 2021 and 2020, the Company recognized an impairment of intangibles in the amount of $0, respectively.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820 Fair Value Measurements and Disclosures establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

 

These tiers include:

Level 1: defined as observable inputs such as quoted prices in active markets;
Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

 

The carrying value of the Company’s cash, other current assets, accounts payable, accrued expenses and advances from related parties approximates its fair value due to their short-term maturity. The Company has derivatives that are measured at level 3. The derivatives may require appropriate valuation adjustments that a market participant would require to arrive at fair value.

 

10

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 
Derivatives

Derivatives

Derivative instruments are recognized in the Consolidated Financial Statements at fair value. Where the Company has entered into master netting agreements with counterparties, the derivative positions are netted by counterparties and are reported accordingly in other assets or other liabilities. Changes in the fair value of derivative instruments are recognized in earnings each period, unless the derivative is designated and qualifies as a cash flow or net investment hedge.

 
Taxes

Income Taxes

The Company accounts for its income taxes in accordance with ASC 740, Income Taxes, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

 
Revenue Recognition

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Update (ASU) 2014-09, “Revenue from contracts with customers” (Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the considerations that the Company expects to receive in exchange for those goods.

 

The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

 

The Company only applies the five-step model to contracts when it is probably that the entity will collect the consideration it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery. For our new customers, the Company generally requires orders placed to be backed by advances or deposits. In general, we provide payment terms between 30 to 60 days following receiving of goods.

 
Cost of Goods Sold

Cost of Goods Sold

Cost of goods sold includes direct costs of selling items, direct labor cost, rent expense and electricity.

 
asic Income (Loss) Per Share

Basic Income (Loss) Per Share

The Company computes income (loss) per share in accordance with ASC 260 Earnings per Share. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of November 30 and May 31, 2021, there were no potentially dilutive debt or equity instruments issued or outstanding.

 
Foreign Currency Translation

Foreign Currency Translation

Assets and liabilities of the Company’s Swiss subsidiary are translated from Swiss francs to United States dollars at exchange rates in effect at the balance sheet date. Income and expenses are translated at average exchange rates during the period. The translation adjustments for the reporting period are included in the Company’s consolidated statements of operations and comprehensive loss, and the cumulative effect of these adjustments are reported in the Company’s consolidated balance sheets as accumulated other comprehensive loss within stockholders’ deficit.

 

11

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

There have been no recent accounting pronouncements or changes in accounting pronouncements during the six months ended November 30, 2021 that are of significance or potential significance to the Company.
XML 28 R20.htm IDEA: XBRL DOCUMENT v3.21.4
ROPERTY AND EQUIPMENT (Tables)
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
Property and equipment:

Property and equipment:

  November 30, 2021   May 31, 2021
Equipment $ 16,451 $ 16,451
Leasehold Improvements   8,354   8,354
Accumulated depreciation   (21,585)   (20,422)
Net property and equipment $ 3,220 $ 4,383
XML 29 R21.htm IDEA: XBRL DOCUMENT v3.21.4
INCOME TAXES (Tables)
 6 Months Ended
Nov. 30, 2021
Accounting Policies [Abstract]  
the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021

The components of the Company’s deferred tax asset and reconciliation of income taxes computed at the new statutory rate of 21% to the income tax amount recorded as of November 30, 2021 and May 31, 2021 are as follows:

 

    November 30, 2021   May 31, 2021
Net operating loss carryforward $ (1,077,681) $ (874,854)
Effective tax rate   21 %   21 %
Deferred tax asset   226,313   183,719
Less: Valuation allowance   (226,313)   (183,719)
Net deferred asset $ - $ -

 

17

 

 

CANNABIS SUISSE CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

The change in the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 was $42,594 and $88,068, respectively.

 

    November 30, 2021   May 31, 2021
Federal income tax benefit attributed to:        
Net operating loss from continuing operations $ 226,313 $ 183,719
Valuation allowance   (226,313)   (183,719)
Net benefit $ - $ -
the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021

The change in the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 was $42,594 and $88,068, respectively.

 

    November 30, 2021   May 31, 2021
Federal income tax benefit attributed to:        
Net operating loss from continuing operations $ 226,313 $ 183,719
Valuation allowance   (226,313)   (183,719)
Net benefit $ - $ -
XML 30 R22.htm IDEA: XBRL DOCUMENT v3.21.4
Property and equipment: (Details) - USD ($)
Nov. 30, 2021
May 31, 2021
Accounting Policies [Abstract]    
Equipment $ 16,451 $ 16,451
Leasehold Improvements 8,354 8,354
Accumulated depreciation (21,585) (20,422)
Net property and equipment $ 3,220 $ 4,383
XML 31 R23.htm IDEA: XBRL DOCUMENT v3.21.4
the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 (Details) - USD ($)
 6 Months Ended 12 Months Ended
Nov. 30, 2021
May 31, 2021
Accounting Policies [Abstract]    
Net operating loss carryforward $ (1,077,681) $ (874,854)
Deferred tax asset 226,313 183,719
Less: Valuation allowance (226,313) (183,719)
Net deferred asset
Federal income tax benefit attributed to:    
Net operating loss from continuing operations 226,313 183,719
Valuation allowance $ (226,313) $ (183,719)
XML 32 cannabis10q_nov21_htm.xml IDEA: XBRL DOCUMENT 0001680132 2021-06-01 2021-11-30 0001680132 2022-01-14 0001680132 2021-11-30 0001680132 2021-05-31 0001680132 2021-09-01 2021-11-30 0001680132 2020-09-01 2020-11-30 0001680132 2020-06-01 2020-11-30 0001680132 us-gaap:PreferredStockMember 2020-05-31 0001680132 us-gaap:CommonStockMember 2020-05-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-05-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-05-31 0001680132 us-gaap:RetainedEarningsMember 2020-05-31 0001680132 2020-05-31 0001680132 us-gaap:PreferredStockMember 2020-06-01 2020-08-31 0001680132 us-gaap:CommonStockMember 2020-06-01 2020-08-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-06-01 2020-08-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-01 2020-08-31 0001680132 us-gaap:RetainedEarningsMember 2020-06-01 2020-08-31 0001680132 2020-06-01 2020-08-31 0001680132 us-gaap:PreferredStockMember 2020-08-31 0001680132 us-gaap:CommonStockMember 2020-08-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-08-31 0001680132 us-gaap:RetainedEarningsMember 2020-08-31 0001680132 2020-08-31 0001680132 us-gaap:PreferredStockMember 2020-09-01 2020-11-30 0001680132 us-gaap:CommonStockMember 2020-09-01 2020-11-30 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-09-01 2020-11-30 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-01 2020-11-30 0001680132 us-gaap:RetainedEarningsMember 2020-09-01 2020-11-30 0001680132 us-gaap:PreferredStockMember 2020-11-30 0001680132 us-gaap:CommonStockMember 2020-11-30 0001680132 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-11-30 0001680132 us-gaap:RetainedEarningsMember 2020-11-30 0001680132 2020-11-30 0001680132 us-gaap:PreferredStockMember 2021-05-31 0001680132 us-gaap:CommonStockMember 2021-05-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-31 0001680132 us-gaap:RetainedEarningsMember 2021-05-31 0001680132 us-gaap:PreferredStockMember 2021-06-01 2021-08-31 0001680132 us-gaap:CommonStockMember 2021-06-01 2021-08-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-06-01 2021-08-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-01 2021-08-31 0001680132 us-gaap:RetainedEarningsMember 2021-06-01 2021-08-31 0001680132 2021-06-01 2021-08-31 0001680132 us-gaap:PreferredStockMember 2021-08-31 0001680132 us-gaap:CommonStockMember 2021-08-31 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-08-31 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-08-31 0001680132 us-gaap:RetainedEarningsMember 2021-08-31 0001680132 2021-08-31 0001680132 us-gaap:PreferredStockMember 2021-09-01 2021-11-30 0001680132 us-gaap:CommonStockMember 2021-09-01 2021-11-30 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-09-01 2021-11-30 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-01 2021-11-30 0001680132 us-gaap:RetainedEarningsMember 2021-09-01 2021-11-30 0001680132 us-gaap:PreferredStockMember 2021-11-30 0001680132 us-gaap:CommonStockMember 2021-11-30 0001680132 us-gaap:AdditionalPaidInCapitalMember 2021-11-30 0001680132 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-11-30 0001680132 us-gaap:RetainedEarningsMember 2021-11-30 0001680132 2020-06-01 2021-05-31 iso4217:USD shares iso4217:USD shares 0001680132 false --05-31 Q2 2022 true false 10-Q true 2021-11-30 false 333-213009 CANNABIS SUISSE CORP. NV 38-3993849 6607 Clara St #270 Bell Gardens CA 90201 502 2082098 manage@cannabissuissecorp.com Yes No Non-accelerated Filer true false 34091975 1734 7770 5962 450 13732 2184 3220 4383 16952 6567 173620 101620 31650 100000 67213 5316 25228 310586 194061 310586 194061 0.001 0.001 20000000 20000000 5000000 5000000 0 0 5000 0.001 0.001 250000000 250000000 31091975 31091975 34500000 34500000 31092 34500 747955 652860 -1077681 -874854 293634 187494 16952 6567 7770 7770 36945 <span style="font-size: 10pt">-</span> <span style="font-size: 10pt">11,226</span> <span style="font-size: 10pt">-</span> <span style="font-size: 10pt">13,905</span> 7770 11226 7770 50850 1734 28841 1734 102648 6036 -17615 6036 -51798 6487 6487 36182 59687 73264 163951 4136 12000 18386 33896 582 4163 1164 8324 47387 78850 99301 206171 41351 93465 93265 257969 17541 62787 1395 1841 15683 48616 -73180 -93465 -202827 -257969 73180 93465 202827 257969 -8528 -8528 73180 101993 202827 266497 -0.00 -0.00 -0.00 -0.00 31091975 34500000 31091975 34500000 34500000 34500 51695 -17221 -455482 -386508 -157 -157 -164504 -164504 34500000 34500 51695 -17378 -619986 -551169 -101993 -101993 34500000 34500 562860 -721979 -124619 34500000 34500 652860 -874854 -187494 1034561 1 63601 64635 5,000,000 5,000 (5,000) -129647 -129647 5000000 5000 30534561 30534 716461 -1004501 -252506 557414 558 31494 32052 -73180 -73180 5000000 5000 31091975 31092 747955 -1077681 -293634 -202827 -266497 1164 8324 78827 12772 62787 48616 1841 7770 1979 8422 9563 -1734 24932 5513 450 81507 72000 11375 -31650 -83068 31650 62048 21015 31650 83063 5 5 <p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zwQc27lRhGba" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 1 – <span id="xdx_82E_zWF4LPzOnu5i">ORGANIZATION AND NATURE OF BUSINESS</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is engaged in the business of production of OTC (over-the-counter) products - for example CBD oils, retail branded cigarettes and also some health-related supplements. We use various distribution channels for various types of customers. The Company’s products can be sold to both corporate customers and individual clients.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zcTX15WtmhIj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 2 – <span id="xdx_829_zYbZ4ugs6GVk">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company's financial position, results of operations and cash flows for the interim periods. The results of operations for the six months ended November 30, 2021 are not necessarily indicative of the results to be expected for the year ending May 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The information included in this Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended May 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_ziENP29Z4Xs4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zhWbblKWZyh7">Basis of presentation and consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, (GAAP). The Company’s year-end is May 31. The consolidated financial statements include the accounts of the Company and its former wholly-owned subsidiary, Cannabis Suisse LLC, through the date of disposal (see Note 4). All significant inter-company accounts and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zqEsLaYkpO46" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zdhJLgHoXV9c">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z4YSe0Nw8gzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.05pt"><span style="text-decoration: underline">Cash</span></span><span style="text-decoration: underline"> and <span id="xdx_86F_znAOZY2b1fog">Cash</span> <span style="letter-spacing: -0.1pt">E</span>q<span style="letter-spacing: -0.05pt">ui</span><span style="letter-spacing: -0.1pt">v</span>a<span style="letter-spacing: -0.05pt">lents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.05pt">T</span>h<span style="letter-spacing: -0.05pt">e C</span>o<span style="letter-spacing: -0.15pt">m</span>p<span style="letter-spacing: -0.05pt">a</span>ny <span style="letter-spacing: -0.05pt">c</span>o<span style="letter-spacing: -0.05pt">nsi</span>d<span style="letter-spacing: -0.05pt">ers all</span> h<span style="letter-spacing: -0.05pt">i</span>gh<span style="letter-spacing: -0.05pt">ly li</span>qu<span style="letter-spacing: -0.1pt">i</span>d <span style="letter-spacing: -0.05pt">inves</span>t<span style="letter-spacing: -0.15pt">m</span><span style="letter-spacing: -0.05pt">e</span>n<span style="letter-spacing: -0.05pt">ts wit</span>h <span style="letter-spacing: -0.05pt">t</span>h<span style="letter-spacing: -0.05pt">e ori</span>g<span style="letter-spacing: -0.1pt">i</span>n<span style="letter-spacing: -0.05pt">a</span>l <span style="letter-spacing: -0.15pt">m</span>atu<span style="letter-spacing: -0.05pt">ritie</span>s <span style="letter-spacing: -0.05pt">o</span>f <span style="letter-spacing: -0.05pt">thre</span>e <span style="letter-spacing: -0.15pt">m</span>on<span style="letter-spacing: -0.05pt">t</span>hs or <span style="letter-spacing: -0.05pt">les</span>s <span style="letter-spacing: -0.05pt">to </span>be ca<span style="letter-spacing: -0.1pt">s</span>h <span style="letter-spacing: -0.1pt">e</span><span style="letter-spacing: -0.05pt">q</span>u<span style="letter-spacing: -0.05pt">i</span>v<span style="letter-spacing: -0.1pt">a</span><span style="letter-spacing: -0.05pt">le</span>n<span style="letter-spacing: -0.05pt">t</span>s. The Company had $0 of cash and cash equivalents as of November 30, 2021 and May 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--AccountsAndNontradeReceivableTextBlock_z146DUxCUOca" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zP1saGG1xqQh"><span id="xdx_86A_zkW2SIDcwoLh">Accounts Receivable</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p id="xdx_847_eus-gaap--InventoryDisclosureTextBlock_zva2EVboZo56" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="text-decoration: underline">I<span id="xdx_866_z2UkGWOM9NQa">nventories</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories are stated at the lower of cost or market. The Company had $0 and $1,734 in inventory as of November 30, 2021 and May 31, 2021, respectively. The Company also determines a reserve for excess and obsolete inventory based on historical usage, and projecting the year in which inventory will be consumed into a finished product. The valuation of inventories requires management to make significant assumptions, including the assessment of market value by inventory category considering historical usage, future usage and market demand for their products, and qualitative judgments related to discontinued, slow moving and obsolete inventories. The Company had $0 in reserve for excess and obsolete inventory as of November 30, 2021 and May 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">9</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zSHVxJk81TJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_z7o1ye98MJMi">Property and equipment</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are carried at cost less accumulated depreciation. Depreciation is provided over the assets’ estimated useful lives, using the straight-line method. Estimated useful lives of the plant and equipment are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Equipment, Furniture and fixtures 5-10 years</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Office machines, IT equipment 5-10 years</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Leasehold Improvements 2-5 years</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of operations and comprehensive loss. The cost of maintenance and repairs is charged to the consolidated statements of operations and comprehensive loss as incurred, whereas significant renewals and betterments are capitalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zf24gvVZoJfl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_z1ZCGOH8Nv76">Impairment</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Our evaluation is based on an assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value of an asset, current or forecasted operating or cash flow losses that demonstrate continuing losses associated with the use of an asset, and a current expectation that, more likely than not, an asset will be disposed of before the end of its previously estimated useful life. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2021 and 2020, the Company recognized an impairment of intangibles in the amount of $0, respectively.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <p id="xdx_844_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zXgPuM9qzZ7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_866_zlOidaZEZBS4">Fair Value of Financial Instruments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounting Standards Codification (“ASC”) 820 <i>Fair Value Measurements and Disclosures</i> establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These tiers include:</p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Level 1:</span></td> <td style="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">defined as observable inputs such as quoted prices in active markets;</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Level 2:</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Level 3:</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company’s cash, other current assets, accounts payable, accrued expenses and advances from related parties approximates its fair value due to their short-term maturity. The Company has derivatives that are measured at level 3. The derivatives may require appropriate valuation adjustments that a market participant would require to arrive at fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">10<br/> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--DerivativesPolicyTextBlock_za7XWJnpabVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zrivyPIB7S97">Derivatives</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Derivative instruments are recognized in the Consolidated Financial Statements at fair value. Where the Company has entered into master netting agreements with counterparties, the derivative positions are netted by counterparties and are reported accordingly in other assets or other liabilities. Changes in the fair value of derivative instruments are recognized in earnings each period, unless the derivative is designated and qualifies as a cash flow or net investment hedge.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--IncomeTaxDisclosureTextBlock_zkRI0oJJHXg6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Income <span id="xdx_86E_zEaVahn5BvOf">Taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its income taxes in accordance with ASC 740, <i>Income Taxes</i>, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_zsoVarhPCYNf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_860_zHRpLSF88ZFd">Revenue Recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Update (ASU) 2014-09, <i>“Revenue from contracts with customers” </i>(Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the considerations that the Company expects to receive in exchange for those goods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company only applies the five-step model to contracts when it is probably that the entity will collect the consideration it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery. For our new customers, the Company generally requires orders placed to be backed by advances or deposits. In general, we provide payment terms between 30 to 60 days following receiving of goods.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--CostOfSalesPolicyTextBlock_zZziRvB067Mj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_860_z5uoTT5nndNe">Cost of Goods Sold</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of goods sold includes direct costs of selling items, direct labor cost, rent expense and electricity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_84A_eus-gaap--ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_zdcCDBhEI4jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">B<span id="xdx_86A_z4y46aZ9xYPi">asic Income (Loss) Per Share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes income (loss) per share in accordance with ASC 260 <i>Earnings per Share</i>. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of November 30 and May 31, 2021, there were no potentially dilutive debt or equity instruments issued or outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"/> <p id="xdx_840_eus-gaap--ForeignCurrencyDisclosureTextBlock_zzhT6TvY3hC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_862_z9A1lPU7oqha">Foreign Currency Translation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assets and liabilities of the Company’s Swiss subsidiary are translated from Swiss francs to United States dollars at exchange rates in effect at the balance sheet date. Income and expenses are translated at average exchange rates during the period. The translation adjustments for the reporting period are included in the Company’s consolidated statements of operations and comprehensive loss, and the cumulative effect of these adjustments are reported in the Company’s consolidated balance sheets as accumulated other comprehensive loss within stockholders’ deficit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">11</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK54k1F4ubC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_zpRf48T9i564">Recent Accounting Pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There have been no recent accounting pronouncements or changes in accounting pronouncements during the six months ended November 30, 2021 that are of significance or potential significance to the Company.</p> <p id="xdx_85D_zjflkYJTcS7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_ziENP29Z4Xs4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zhWbblKWZyh7">Basis of presentation and consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, (GAAP). The Company’s year-end is May 31. The consolidated financial statements include the accounts of the Company and its former wholly-owned subsidiary, Cannabis Suisse LLC, through the date of disposal (see Note 4). All significant inter-company accounts and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zqEsLaYkpO46" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zdhJLgHoXV9c">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z4YSe0Nw8gzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.05pt"><span style="text-decoration: underline">Cash</span></span><span style="text-decoration: underline"> and <span id="xdx_86F_znAOZY2b1fog">Cash</span> <span style="letter-spacing: -0.1pt">E</span>q<span style="letter-spacing: -0.05pt">ui</span><span style="letter-spacing: -0.1pt">v</span>a<span style="letter-spacing: -0.05pt">lents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.05pt">T</span>h<span style="letter-spacing: -0.05pt">e C</span>o<span style="letter-spacing: -0.15pt">m</span>p<span style="letter-spacing: -0.05pt">a</span>ny <span style="letter-spacing: -0.05pt">c</span>o<span style="letter-spacing: -0.05pt">nsi</span>d<span style="letter-spacing: -0.05pt">ers all</span> h<span style="letter-spacing: -0.05pt">i</span>gh<span style="letter-spacing: -0.05pt">ly li</span>qu<span style="letter-spacing: -0.1pt">i</span>d <span style="letter-spacing: -0.05pt">inves</span>t<span style="letter-spacing: -0.15pt">m</span><span style="letter-spacing: -0.05pt">e</span>n<span style="letter-spacing: -0.05pt">ts wit</span>h <span style="letter-spacing: -0.05pt">t</span>h<span style="letter-spacing: -0.05pt">e ori</span>g<span style="letter-spacing: -0.1pt">i</span>n<span style="letter-spacing: -0.05pt">a</span>l <span style="letter-spacing: -0.15pt">m</span>atu<span style="letter-spacing: -0.05pt">ritie</span>s <span style="letter-spacing: -0.05pt">o</span>f <span style="letter-spacing: -0.05pt">thre</span>e <span style="letter-spacing: -0.15pt">m</span>on<span style="letter-spacing: -0.05pt">t</span>hs or <span style="letter-spacing: -0.05pt">les</span>s <span style="letter-spacing: -0.05pt">to </span>be ca<span style="letter-spacing: -0.1pt">s</span>h <span style="letter-spacing: -0.1pt">e</span><span style="letter-spacing: -0.05pt">q</span>u<span style="letter-spacing: -0.05pt">i</span>v<span style="letter-spacing: -0.1pt">a</span><span style="letter-spacing: -0.05pt">le</span>n<span style="letter-spacing: -0.05pt">t</span>s. The Company had $0 of cash and cash equivalents as of November 30, 2021 and May 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--AccountsAndNontradeReceivableTextBlock_z146DUxCUOca" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zP1saGG1xqQh"><span id="xdx_86A_zkW2SIDcwoLh">Accounts Receivable</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p id="xdx_847_eus-gaap--InventoryDisclosureTextBlock_zva2EVboZo56" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="text-decoration: underline">I<span id="xdx_866_z2UkGWOM9NQa">nventories</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories are stated at the lower of cost or market. The Company had $0 and $1,734 in inventory as of November 30, 2021 and May 31, 2021, respectively. The Company also determines a reserve for excess and obsolete inventory based on historical usage, and projecting the year in which inventory will be consumed into a finished product. The valuation of inventories requires management to make significant assumptions, including the assessment of market value by inventory category considering historical usage, future usage and market demand for their products, and qualitative judgments related to discontinued, slow moving and obsolete inventories. The Company had $0 in reserve for excess and obsolete inventory as of November 30, 2021 and May 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">9</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zSHVxJk81TJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_z7o1ye98MJMi">Property and equipment</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are carried at cost less accumulated depreciation. Depreciation is provided over the assets’ estimated useful lives, using the straight-line method. Estimated useful lives of the plant and equipment are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Equipment, Furniture and fixtures 5-10 years</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Office machines, IT equipment 5-10 years</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Leasehold Improvements 2-5 years</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of operations and comprehensive loss. The cost of maintenance and repairs is charged to the consolidated statements of operations and comprehensive loss as incurred, whereas significant renewals and betterments are capitalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zf24gvVZoJfl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_z1ZCGOH8Nv76">Impairment</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Our evaluation is based on an assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value of an asset, current or forecasted operating or cash flow losses that demonstrate continuing losses associated with the use of an asset, and a current expectation that, more likely than not, an asset will be disposed of before the end of its previously estimated useful life. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended November 30, 2021 and 2020, the Company recognized an impairment of intangibles in the amount of $0, respectively.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <p id="xdx_844_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zXgPuM9qzZ7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_866_zlOidaZEZBS4">Fair Value of Financial Instruments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounting Standards Codification (“ASC”) 820 <i>Fair Value Measurements and Disclosures</i> establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These tiers include:</p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Level 1:</span></td> <td style="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">defined as observable inputs such as quoted prices in active markets;</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Level 2:</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Level 3:</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company’s cash, other current assets, accounts payable, accrued expenses and advances from related parties approximates its fair value due to their short-term maturity. The Company has derivatives that are measured at level 3. The derivatives may require appropriate valuation adjustments that a market participant would require to arrive at fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">10<br/> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--DerivativesPolicyTextBlock_za7XWJnpabVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zrivyPIB7S97">Derivatives</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Derivative instruments are recognized in the Consolidated Financial Statements at fair value. Where the Company has entered into master netting agreements with counterparties, the derivative positions are netted by counterparties and are reported accordingly in other assets or other liabilities. Changes in the fair value of derivative instruments are recognized in earnings each period, unless the derivative is designated and qualifies as a cash flow or net investment hedge.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--IncomeTaxDisclosureTextBlock_zkRI0oJJHXg6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Income <span id="xdx_86E_zEaVahn5BvOf">Taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its income taxes in accordance with ASC 740, <i>Income Taxes</i>, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_zsoVarhPCYNf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_860_zHRpLSF88ZFd">Revenue Recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Update (ASU) 2014-09, <i>“Revenue from contracts with customers” </i>(Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the considerations that the Company expects to receive in exchange for those goods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company only applies the five-step model to contracts when it is probably that the entity will collect the consideration it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery. For our new customers, the Company generally requires orders placed to be backed by advances or deposits. In general, we provide payment terms between 30 to 60 days following receiving of goods.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--CostOfSalesPolicyTextBlock_zZziRvB067Mj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_860_z5uoTT5nndNe">Cost of Goods Sold</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of goods sold includes direct costs of selling items, direct labor cost, rent expense and electricity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_84A_eus-gaap--ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_zdcCDBhEI4jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">B<span id="xdx_86A_z4y46aZ9xYPi">asic Income (Loss) Per Share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes income (loss) per share in accordance with ASC 260 <i>Earnings per Share</i>. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of November 30 and May 31, 2021, there were no potentially dilutive debt or equity instruments issued or outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"/> <p id="xdx_840_eus-gaap--ForeignCurrencyDisclosureTextBlock_zzhT6TvY3hC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_862_z9A1lPU7oqha">Foreign Currency Translation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assets and liabilities of the Company’s Swiss subsidiary are translated from Swiss francs to United States dollars at exchange rates in effect at the balance sheet date. Income and expenses are translated at average exchange rates during the period. The translation adjustments for the reporting period are included in the Company’s consolidated statements of operations and comprehensive loss, and the cumulative effect of these adjustments are reported in the Company’s consolidated balance sheets as accumulated other comprehensive loss within stockholders’ deficit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">11</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK54k1F4ubC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_zpRf48T9i564">Recent Accounting Pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There have been no recent accounting pronouncements or changes in accounting pronouncements during the six months ended November 30, 2021 that are of significance or potential significance to the Company.</p> <p id="xdx_802_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zV3YYIzOD1Gj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 3 – <span><span id="xdx_82D_zika1MpMhc9f">GOING CONCERN</span></span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. However, the Company had limited revenues and recurring losses as of November 30, 2021. The Company has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company’s ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. In light of management’s efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The impact of the COVID-19 pandemic has had, and is expected to continue to have, an adverse effect on our business and our financial results. COVID-19 pandemic has negatively affected global economy, disrupted consumer spending and global supply chains and created significant volatility and disruption of financial markets. The pandemic had and will continue to have an adverse effect on our business and financial performance. The extent of the impact of COVID-19, including the Company’s ability to execute its business strategies as planned, will depend on future developments, including the duration and severity of the pandemic, which are uncertain and cannot be predicted. The COVID-19 pandemic could also adversely affect its liquidity and ability to access the capital markets. Uncertainty regarding the duration of the COVID-19 pandemic may adversely impact its ability to raise additional capital, or require additional capital.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p id="xdx_809_eus-gaap--BusinessCombinationsPolicy_ztvmUX2KmIu5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><span style="text-decoration: underline">NOTE 4 - <span id="xdx_82D_z3oTh1rR7ur6">BUSINESS COMBINATION</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 23, 2020, Cannabis Suisse Corp. (the “Transferor”), entered into an Asset Transfer Agreement with Cecillia Merige Jensen (the “Transferee”) and Cannabis Suisse LLC. In accordance with the terms of the Agreement, the Transferor transferred to the Transferee all its right, title and interest to one hundred percent (100%) of Cannabis Suisse LLC, including all its right, title and interest to one hundred percent (100%) of Grow Factory GmbH and the Transferee transferred and assigned to the Transferor 10,000,000 restricted shares of Cannabis Suisse Corp., free and clear of any and all liens and encumbrances. The above-mentioned Asset Transfer Agreement hereby revokes the effect of the Stock Transfer Agreement entered into with Cecillia Jensen on May 31, 2019, and the 10,000,000 shares were returned to the President of the Company to reinstate his ownership percentage pre-acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 78%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Disposal of Assets:</span></td> <td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 23pt; text-align: justify; text-indent: -4.5pt"><span style="font-size: 10pt">Related Party Receivable</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">1,618</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">       Inventory</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">29,902</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">       Prepaid Taxes</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">12,346</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 18.25pt"><span style="font-size: 10pt">Property and Equipment</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">71,006</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 18.5pt"><span style="font-size: 10pt">VAT Tax Receivable</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">4,316</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 18.5pt"><span style="font-size: 10pt">Operating lease right of use asset</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">126,881</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 31.75pt"><span style="font-size: 10pt">Total Assets Transferred</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt"> $</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">246,069</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">12</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts_zxgvQBj06d6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 5 – P<span id="xdx_827_zhBo8op3lZSe">ROPERTY AND EQUIPMENT</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_zaM2kET6lsd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B6_z4nFqh4h9sr">Property and equipment:</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_493_20211130_z9BOKuYbnpS" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>November 30, 2021</b></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_494_20210531_zlVG0Nks2sS2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>May 31, 2021</b></span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_zR9WYGa7FaGf"> <td style="vertical-align: top; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Equipment</span></td> <td style="vertical-align: top; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">16,451</span></td> <td style="vertical-align: top; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">16,451</span></td></tr> <tr id="xdx_403_eus-gaap--LeaseholdImprovementsGross_iI_zevekEDBMq05"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Leasehold Improvements</span></td> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">8,354</span></td> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">8,354</span></td></tr> <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zoUpZR51D95g" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Accumulated depreciation</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(21,585)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(20,422)</span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentOwnedNet_iI_zrK4d9AyoT3j" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt"><b>Net property and equipment</b></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">3,220</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">4,383</span></td></tr> </table> <p id="xdx_8A9_ztTbxC39nHPc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended November 30, 2021 and 2020 the Company recognized depreciation expense in the amount of $582 and $4,163, respectively. For the six months ended November 30, 2021 and 2020 the Company recognized depreciation expense in the amount of $1,164 and $8,324, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_zaM2kET6lsd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B6_z4nFqh4h9sr">Property and equipment:</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_493_20211130_z9BOKuYbnpS" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>November 30, 2021</b></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_494_20210531_zlVG0Nks2sS2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>May 31, 2021</b></span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_zR9WYGa7FaGf"> <td style="vertical-align: top; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Equipment</span></td> <td style="vertical-align: top; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">16,451</span></td> <td style="vertical-align: top; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">16,451</span></td></tr> <tr id="xdx_403_eus-gaap--LeaseholdImprovementsGross_iI_zevekEDBMq05"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Leasehold Improvements</span></td> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">8,354</span></td> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">8,354</span></td></tr> <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zoUpZR51D95g" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Accumulated depreciation</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(21,585)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(20,422)</span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentOwnedNet_iI_zrK4d9AyoT3j" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt"><b>Net property and equipment</b></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">3,220</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">4,383</span></td></tr> </table> 16451 16451 8354 8354 21585 20422 3220 4383 <p id="xdx_804_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zhLa21eCVTWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><span style="text-decoration: underline">NOTE 6 – <span id="xdx_821_zJ1zRPKzW6Ha">COMMITMENTS AND CONTINGENCIES</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">As of November 30, 2021 the Company has no signed agreements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zloYmvp647g9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 7 – <span id="xdx_82C_zPcmlm6V8hKk">RELATED/THIRD PARTY TRANSACTIONS</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s President has agreed to provide interest free advances, due on demand, to the Company up to $100,000. As of November 30 and May 31, 2021, Suneetha Nandana Silva Sudusinghe advanced to the Company $31,650 and $0, respectively.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_80A_eus-gaap--ConvertibleDebtTableTextBlock_zMafNrxY6N59" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 8 – <span id="xdx_821_zST0KwoEz6Lg">CONVERTIBLE NOTES PAYABLE</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 1, 2020, Suneetha Nandana Silva Sudusinghe assigned SAPA Investments, LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows SAPA Investments, LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 4, 2020 Suneetha Nandana Silva Sudusinghe assigned SAPA Group, LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows SAPA Group, LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 7, 2020 Suneetha Nandana Silva Sudusinghe assigned GSS Group LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows GSS Group LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 10, 2020 Suneetha Nandana Silva Sudusinghe assigned Noi Tech LLC $10,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Noi Tech LLC to convert the loan to common stock at a 70%-discount to the market price at the time of conversion after a period of lockup of 30 days.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">13</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 1, 2021 Suneetha Nandana Silva Sudusinghe assigned Serhii Cherniienko $60,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Serhii Cherniienko to convert the loan to common stock at a fixed price of $0.01 per share. Beneficial conversion feature was $60,000 and debt discount was $19,672.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 15, 2021 Suneetha Nandana Silva Sudusinghe assigned Noi Tech LLC $30,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Noi Tech LLC to convert the loan to common stock at a fixed price of $0.01 per share. Beneficial conversion feature was $30,000 and debt discount was $7,541.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s convertible promissory notes gave rise to derivative financial instruments. The notes embodied certain terms and conditions that were not clearly and closely related to the host debt agreement in terms of economic risks and characteristics. These terms and features consist of the embedded conversion option.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following tables summarize the components of the Company’s derivative liabilities and linked common shares as of November 30, 2021 and the amounts that were reflected in income related to derivatives for the period ended:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">November 30, 2021</span></td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: left"><span style="font-size: 10pt">The financings giving rise to derivative financial instruments</span></td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">Indexed<br/> Shares</span></td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">Fair<br/> Values</span></td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 60%; padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">Embedded derivatives</span></td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; text-align: right"><span style="font-size: 10pt">433,674</span></td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%; text-align: left"><span style="font-size: 10pt">$ </span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; text-align: right"><span style="font-size: 10pt">5,315</span></td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">Total</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">433,674</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: black 2.25pt double; text-align: left"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">5,315</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the three and six months ended November 30, 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.1pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td rowspan="2" style="border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">The financings giving rise to derivative financial instruments and the gain (loss) effects:</span></td> <td rowspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">For the Three Months Ended</span></td> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">For the Six Months Ended</span></td></tr> <tr> <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">November 30, 2021</span></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">November 30, 2021</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Embedded derivatives</span></td> <td style="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">$</span></td> <td style="border-top: Black 1.5pt solid; border-bottom: Black 1pt solid; width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">                    1,395 </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">1,841</span></td></tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Total</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">                    1,395 </span></td> <td style="border-bottom: black 2.25pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">1,841</span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Current accounting principles that are provided in ASC 815 - <i>Derivatives and Hedging</i> require derivative financial instruments to be classified in liabilities and carried at fair value with changes recorded in income. The Company has selected the Monte Carlo Simulation Model valuation technique to fair value the embedded derivative because it believes that this technique is reflective of all significant assumption types, and ranges of assumption inputs, that market participants would likely consider in transactions involving embedded derivatives. Such assumptions include, among other inputs, interest risk assumptions, credit risk assumptions and redemption behaviors in addition to traditional inputs for option models such as market trading volatility and risk-free rates. The Monte Carlo Simulation Model technique is a level three valuation technique because it requires the development of significant internal assumptions in addition to observable market indicators. For instruments in which the time to expiration has expired, the Company has utilized the intrinsic value as the fair value. The intrinsic value is the difference between the quoted market price on the valuation date and the applicable conversion price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">14<br/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant inputs and results arising from the Monte Carlo Simulation process are as follows for the embedded derivatives that have been bifurcated from the convertible notes and classified in liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 74%; text-align: left"> </td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; width: 22%; text-align: center"><span style="font-size: 10pt">December 1, 2020</span></td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Quoted market price on valuation date</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.0615</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Effective contractual conversion rates</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.044</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Contractual term to maturity</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.25 years</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Market volatility:</span></td> <td style="text-align: left"> </td> <td style="text-align: center"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: left"><span style="font-size: 10pt">Volatility</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">299.09% - 479.35%</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Risk-adjusted interest rate</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.13%</span></td> <td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 74%; text-align: left"> </td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; width: 22%; text-align: center"><span style="font-size: 10pt">December 4, 2020</span></td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Quoted market price on valuation date</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.0722</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Effective contractual conversion rates</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.056</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Contractual term to maturity</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.25 years</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Market volatility:</span></td> <td style="text-align: left"> </td> <td style="text-align: center"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: left"><span style="font-size: 10pt">Volatility</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">239.43% - 391.85%</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Risk-adjusted interest rate</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.13%</span></td> <td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 74%; text-align: left"> </td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; width: 22%; text-align: center"><span style="font-size: 10pt">December 7, 2020</span></td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Quoted market price on valuation date</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.06</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Effective contractual conversion rates</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.0455</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Contractual term to maturity</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.25 years</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Market volatility:</span></td> <td style="text-align: left"> </td> <td style="text-align: center"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: left"><span style="font-size: 10pt">Volatility</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">281.02% - 381.87%</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Risk-adjusted interest rate</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.12%</span></td> <td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 74%; text-align: left"> </td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; width: 22%; text-align: center"><span style="font-size: 10pt">December 10, 2020</span></td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Quoted market price on valuation date</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.0551</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Effective contractual conversion rates</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.0419</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Contractual term to maturity</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.25 years</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Market volatility:</span></td> <td style="text-align: left"> </td> <td style="text-align: center"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: left"><span style="font-size: 10pt">Volatility</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">196.85% - 382.99%</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Risk-adjusted interest rate</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.12%</span></td> <td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 74%; text-align: left"> </td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; width: 22%; text-align: center"><span style="font-size: 10pt">November 30, 2021</span></td> <td style="width: 2%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Quoted market price on valuation date</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.034</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Effective contractual conversion rates</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">$0.0238</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: left"><span style="font-size: 10pt">Contractual term to maturity</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.25 years</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Market volatility:</span></td> <td style="text-align: left"> </td> <td style="text-align: center"> </td> <td style="text-align: left"> </td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 74%; padding-left: 10pt; text-align: left"><span style="font-size: 10pt">Volatility</span></td> <td style="width: 2%; text-align: left"> </td> <td style="width: 22%; text-align: center"><span style="font-size: 10pt">13.14% - 158.27%</span></td> <td style="width: 2%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><span style="font-size: 10pt">Risk-adjusted interest rate</span></td> <td style="text-align: left"> </td> <td style="text-align: center"><span style="font-size: 10pt">0.08%</span></td> <td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">15</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table reflects the issuances of embedded derivatives and changes in fair value inputs and assumptions related to the embedded derivatives as of November 30 and May 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td rowspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td rowspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Period Ended</span></td> <td rowspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Period Ended</span></td></tr> <tr> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">November 30, 2021</span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">May 31, 2021</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="white-space: nowrap; width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Balances at beginning of period</span></td> <td style="white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">$</span></td> <td style="white-space: nowrap; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">25,228</span></td> <td style="white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">$</span></td> <td style="white-space: nowrap; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td></tr> <tr style="background-color: white"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Issuances:</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">  Embedded derivatives</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">33,132</span></td></tr> <tr> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Conversions</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">        (18,071)</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="background-color: #CDEBFF"> <td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Changes in fair value inputs and assumptions reflected in income</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(1,841)</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(7,904)</span></td></tr> <tr> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="background-color: #CDEBFF"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Balances at end of period</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">5,316</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">25,228</span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p id="xdx_80E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zGbhiFYwgPp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 9 – <span id="xdx_822_zc74lbennbf7">REPORTABLE SEGMENTS</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows segment reporting in accordance with ASC Topic 280, <i>Segment Reporting</i>. As a result of the business combination with Cannabis Suisse LLC in May 2019, the Company has changed its operating segments to consist of the Cannabis Suisse LLC segment and the Cannabis Suisse Corp segment. After the Cannabis Suisse LLC business combination, the Company's CEO began assessing performance and allocating resources based on the financial information of these two reporting segments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Cannabis Suisse LLC segment is involved in cannabis cultivation and distribution in Switzerland of recreational tobacco products and medical CBD oils. On November 23, 2020, Cannabis Suisse LLC and Cannabis Suisse Corp canceled their acquisition by Asset Transfer Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cannabis Suisse Corp is engaged in the development of its business activities by conquering the USA market of CBD products since November 2020.</p> <p style="font: 10pt Helvetica Neue; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Net revenue by reporting segment for the three and six months ended November 30, 2021 and 2020, is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the three</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>November 30, 2021</b></p></td> <td style="text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the six</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>November 30, 2021</b></p></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the three</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>November 30, 2020</b></p></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the six</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>November 30, 2020</b></p></td></tr> <tr style="vertical-align: top"> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Cannabis Suisse Corp</span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">7,770</span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">7,770</span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Cannabis Suisse LLC</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">    -</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">    -</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">11,226</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">50,850</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">    Total Revenue</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">7,770</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">7,770</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">11,226</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">50,850</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Gross profit by reporting segment for the three and six months ended November 30, 2021 and 2020, is as follows:</p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the three</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>November 30, 2021</b></p></td> <td style="text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the six</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>November 30, 2021</b></p></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the three</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>November 30, 2020</b></p></td> <td style="text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the six</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>November 30, 2020</b></p></td></tr> <tr style="vertical-align: top"> <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Cannabis Suisse Corp</span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">6,036</span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">6,036</span></td> <td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Cannabis Suisse LLC</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(17,615)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(51,798)</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">    Total Gross (Loss) Profit</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">6,036</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">6,036</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(17,615)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(51,798)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Assets by reporting segment as of November 30 and May 31, 2021, is as follows:</p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>November 30, 2021</b></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>May 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2021</b></p></td></tr> <tr style="vertical-align: top"> <td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Cannabis Suisse Corp</span></td> <td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">16,952</span></td> <td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">6,567</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Cannabis Suisse LLC</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">    Total Assets</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">16,952</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">6,567</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">16</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b> </b></p> <p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zJnQQAYFdaeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="background-color: white"><b><span style="text-decoration: underline">NOTE 10 – <span id="xdx_820_zZISocAbxVSa">STOCKHOLDERS’ EQUITY</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">On March 17, 2021, the Board of Directors, along with the majority stockholder, resolved that the 5,000,000 preferred shares with voting rights of 1 to 10 shall be issued to Suneetha Nandana Silva Sudusinghe in exchange for 5,000,000 common shares that Suneetha Nandana Silva Sudusinghe owned previously.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The 5,000,000 preferred shares were issued on July 21, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_801_eus-gaap--IncomeTaxPolicyTextBlock_z8c3Omjl6jq" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 11 –<span id="xdx_827_zRxpDnP5kjR8"> INCOME TAXES</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of uncertain tax positions as addressed in ASC 740-10-65-1. As a result of the implementation of ASC 740-10-65-1, the Company recognized no increase in the liability for unrecognized tax benefits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has no tax position at November 30, 2021 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the period presented. The Company had no accruals for interest and penalties at November 30, 2021. The Company’s utilization of any net operating loss carryforward may be unlikely as a result of its intended activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: black">The valuation allowance at November 30, 2021 was $</span>226,313<span style="color: black">. The net change in valuation allowance for the six months ended November 30, 2021 and year ended May 31, 2021 was $42,594 and $88,068, respectively. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on consideration of these items, management has determined that enough uncertainty exists relative to the realization of the deferred income tax asset balances to warrant the application of a full valuation allowance as of November 30 and May 31, 2021. All tax years since inception remains open for examination only by taxing authorities of US Federal and state of Nevada.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a net operating loss carryforward for tax purposes totaling $1,077,681 at November 30, 2021, expiring through fiscal year 2036. There is a limitation on the amount of taxable income that can be offset by carryforwards after a change in control (generally greater than a 50% change in ownership).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zMA76T8xOc7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The components of the Company’s<span id="xdx_8BA_z8gim2NMpSt2"> deferred tax asset</span> and reconciliation of income taxes computed at the new statutory rate of 21% to the income tax amount recorded as of November 30, 2021 and May 31, 2021 are as follows:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_49C_20211130_zOEbOCdPjxw2" style="border-bottom: Black 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>November 30, 2021</b></span></td> <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_497_20210531_ztVciiYp2bSf" style="border-bottom: Black 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>May 31, 2021</b></span></td></tr> <tr id="xdx_40F_eus-gaap--OperatingLossCarryforwards_iNI_di_z4NS4IFoobO5" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Net operating loss carryforward</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(1,077,681)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(874,854)</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt; background-color: white">Effective tax rate</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">21 %</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">21 %</span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zxRm33hrhaT" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Deferred tax asset</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">226,313</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">183,719</span></td></tr> <tr id="xdx_401_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iNI_di_z5ChYaLnNs15" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Less: Valuation allowance</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(226,313)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(183,719)</span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_zzOxJql25m7d" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Net deferred asset</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0566">-</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">17</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlGS999mTNsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The change in <span id="xdx_8BC_zWz6okrDu3Wb">the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021</span> was $42,594 and $88,068, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_496_20210601__20211130_zE5K60ZuG9f6" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>November 30, 2021</b></span></td> <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_49A_20200601__20210531_zV1ZIcfqYUhb" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>May 31, 2021</b></span></td></tr> <tr id="xdx_405_eus-gaap--ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zbP6LEn3KOQ6" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Federal income tax benefit attributed to:</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_zd6CUODC7Fcg" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Net operating loss from continuing operations</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">226,313</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">183,719</span></td></tr> <tr id="xdx_408_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_zIzFEOPXtDTh" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Valuation allowance</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(226,313)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(183,719)</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Net benefit</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td></tr> </table> <p id="xdx_8A7_z8d3oPz8ta62" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zMA76T8xOc7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The components of the Company’s<span id="xdx_8BA_z8gim2NMpSt2"> deferred tax asset</span> and reconciliation of income taxes computed at the new statutory rate of 21% to the income tax amount recorded as of November 30, 2021 and May 31, 2021 are as follows:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_49C_20211130_zOEbOCdPjxw2" style="border-bottom: Black 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>November 30, 2021</b></span></td> <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_497_20210531_ztVciiYp2bSf" style="border-bottom: Black 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>May 31, 2021</b></span></td></tr> <tr id="xdx_40F_eus-gaap--OperatingLossCarryforwards_iNI_di_z4NS4IFoobO5" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Net operating loss carryforward</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(1,077,681)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(874,854)</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt; background-color: white">Effective tax rate</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">21 %</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">21 %</span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zxRm33hrhaT" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Deferred tax asset</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">226,313</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">183,719</span></td></tr> <tr id="xdx_401_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iNI_di_z5ChYaLnNs15" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Less: Valuation allowance</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(226,313)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(183,719)</span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_zzOxJql25m7d" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Net deferred asset</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0566">-</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">17</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CANNABIS SUISSE CORP.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlGS999mTNsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The change in <span id="xdx_8BC_zWz6okrDu3Wb">the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021</span> was $42,594 and $88,068, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_496_20210601__20211130_zE5K60ZuG9f6" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>November 30, 2021</b></span></td> <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_49A_20200601__20210531_zV1ZIcfqYUhb" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>May 31, 2021</b></span></td></tr> <tr id="xdx_405_eus-gaap--ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zbP6LEn3KOQ6" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Federal income tax benefit attributed to:</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_zd6CUODC7Fcg" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Net operating loss from continuing operations</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">226,313</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">183,719</span></td></tr> <tr id="xdx_408_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_zIzFEOPXtDTh" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Valuation allowance</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(226,313)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(183,719)</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Net benefit</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td></tr> </table> 1077681 874854 226313 183719 226313 183719 <p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlGS999mTNsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The change in <span id="xdx_8BC_zWz6okrDu3Wb">the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021</span> was $42,594 and $88,068, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_496_20210601__20211130_zE5K60ZuG9f6" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>November 30, 2021</b></span></td> <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td id="xdx_49A_20200601__20210531_zV1ZIcfqYUhb" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>May 31, 2021</b></span></td></tr> <tr id="xdx_405_eus-gaap--ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zbP6LEn3KOQ6" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Federal income tax benefit attributed to:</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_zd6CUODC7Fcg" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Net operating loss from continuing operations</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">226,313</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">183,719</span></td></tr> <tr id="xdx_408_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_zIzFEOPXtDTh" style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Valuation allowance</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(226,313)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">(183,719)</span></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-size: 10pt">Net benefit</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">-</span></td></tr> </table> 226313 183719 -226313 -183719 <p id="xdx_802_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_z9PyfUzBsB2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 12 –<span id="xdx_82F_zCvLjcgSoOHh"> SUBSEQUENT EVENTS</span></span></b></p> <p/> <p style="text-align: justify"><span style="font-size: 10pt">In accordance with SFAS 165 (ASC 855), Subsequent Events the Company has analyzed its operations subsequent to November 30, 2021 to the date these consolidated financial statements were issued, and has determined that it has material subsequent events to disclose as follows:</span></p> <p style="text-align: justify"><span style="font-size: 10pt">On December 1, 2021, Suneetha Nandana Silva Sudusinghe assigned Serghei Dumanov $12,000 of his loan to Cannabis Suisse Corp. The Agreement contains a provision that allows Serghei Dumanov to convert the loan to common stock at a fixed price of $0.005 per share. The original loan to Cannabis Suisse Corp. from Mr. Sudusinghe was pursuant to Loan Agreement dated March 1, 2016 and Verbal Agreement dated April 2, 2019</span>.</p> EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 36 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 64 244 1 false 5 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://manage@cannabissuissecorp.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS Sheet http://manage@cannabissuissecorp.com/role/BalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENTS OF OPERATIONS Sheet http://manage@cannabissuissecorp.com/role/StatementsOfOperations STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - Statements of Changes in Stockholders Equity Sheet http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity Statements of Changes in Stockholders Equity Statements 5 false false R6.htm 00000006 - Statement - STATEMENTS OF CASH FLOWS Sheet http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS Sheet http://manage@cannabissuissecorp.com/role/OrganizationAndNatureOfBusiness ORGANIZATION AND NATURE OF BUSINESS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://manage@cannabissuissecorp.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - BUSINESS COMBINATION Sheet http://manage@cannabissuissecorp.com/role/BusinessCombination BUSINESS COMBINATION Notes 10 false false R11.htm 00000011 - Disclosure - ROPERTY AND EQUIPMENT Sheet http://manage@cannabissuissecorp.com/role/RopertyAndEquipment ROPERTY AND EQUIPMENT Notes 11 false false R12.htm 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://manage@cannabissuissecorp.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 12 false false R13.htm 00000013 - Disclosure - RELATED/THIRD PARTY TRANSACTIONS Sheet http://manage@cannabissuissecorp.com/role/RelatedthirdPartyTransactions RELATED/THIRD PARTY TRANSACTIONS Notes 13 false false R14.htm 00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://manage@cannabissuissecorp.com/role/ConvertibleNotesPayable CONVERTIBLE NOTES PAYABLE Notes 14 false false R15.htm 00000015 - Disclosure - REPORTABLE SEGMENTS Sheet http://manage@cannabissuissecorp.com/role/ReportableSegments REPORTABLE SEGMENTS Notes 15 false false R16.htm 00000016 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://manage@cannabissuissecorp.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 16 false false R17.htm 00000017 - Disclosure - INCOME TAXES Sheet http://manage@cannabissuissecorp.com/role/IncomeTaxes INCOME TAXES Notes 17 false false R18.htm 00000018 - Disclosure - SUBSEQUENT EVENTS Sheet http://manage@cannabissuissecorp.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 18 false false R19.htm 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 19 false false R20.htm 00000020 - Disclosure - ROPERTY AND EQUIPMENT (Tables) Sheet http://manage@cannabissuissecorp.com/role/RopertyAndEquipmentTables ROPERTY AND EQUIPMENT (Tables) Tables http://manage@cannabissuissecorp.com/role/RopertyAndEquipment 20 false false R21.htm 00000021 - Disclosure - INCOME TAXES (Tables) Sheet http://manage@cannabissuissecorp.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://manage@cannabissuissecorp.com/role/IncomeTaxes 21 false false R22.htm 00000022 - Disclosure - Property and equipment: (Details) Sheet http://manage@cannabissuissecorp.com/role/PropertyAndEquipmentDetails Property and equipment: (Details) Details 22 false false R23.htm 00000023 - Disclosure - the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 (Details) Sheet http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 (Details) Details 23 false false All Reports Book All Reports cannabis10q_nov21.htm ex31.htm ex32.htm none-20211130.xsd none-20211130_cal.xml none-20211130_def.xml none-20211130_lab.xml none-20211130_pre.xml http://xbrl.sec.gov/dei/2021q4 http://fasb.org/us-gaap/2021-01-31 true true JSON 39 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cannabis10q_nov21.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 64, "dts": { "calculationLink": { "local": [ "none-20211130_cal.xml" ] }, "definitionLink": { "local": [ "none-20211130_def.xml" ] }, "inline": { "local": [ "cannabis10q_nov21.htm" ] }, "labelLink": { "local": [ "none-20211130_lab.xml" ] }, "presentationLink": { "local": [ "none-20211130_pre.xml" ] }, "schema": { "local": [ "none-20211130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 217, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 76, "http://xbrl.sec.gov/dei/2021q4": 7, "total": 83 }, "keyCustom": 0, "keyStandard": 244, "memberCustom": 0, "memberStandard": 5, "nsprefix": "none", "nsuri": "http://manage@cannabissuissecorp.com/20211130", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://manage@cannabissuissecorp.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationsPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - BUSINESS COMBINATION", "role": "http://manage@cannabissuissecorp.com/role/BusinessCombination", "shortName": "BUSINESS COMBINATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationsPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - ROPERTY AND EQUIPMENT", "role": "http://manage@cannabissuissecorp.com/role/RopertyAndEquipment", "shortName": "ROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://manage@cannabissuissecorp.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - RELATED/THIRD PARTY TRANSACTIONS", "role": "http://manage@cannabissuissecorp.com/role/RelatedthirdPartyTransactions", "shortName": "RELATED/THIRD PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE", "role": "http://manage@cannabissuissecorp.com/role/ConvertibleNotesPayable", "shortName": "CONVERTIBLE NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - REPORTABLE SEGMENTS", "role": "http://manage@cannabissuissecorp.com/role/ReportableSegments", "shortName": "REPORTABLE SEGMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "role": "http://manage@cannabissuissecorp.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - INCOME TAXES", "role": "http://manage@cannabissuissecorp.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - SUBSEQUENT EVENTS", "role": "http://manage@cannabissuissecorp.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2021-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - BALANCE SHEETS", "role": "http://manage@cannabissuissecorp.com/role/BalanceSheets", "shortName": "BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2021-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - ROPERTY AND EQUIPMENT (Tables)", "role": "http://manage@cannabissuissecorp.com/role/RopertyAndEquipmentTables", "shortName": "ROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxPolicyTextBlock", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - INCOME TAXES (Tables)", "role": "http://manage@cannabissuissecorp.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxPolicyTextBlock", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Property and equipment: (Details)", "role": "http://manage@cannabissuissecorp.com/role/PropertyAndEquipmentDetails", "shortName": "Property and equipment: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxPolicyTextBlock", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 (Details)", "role": "http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details", "shortName": "the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxPolicyTextBlock", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2021-11-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - BALANCE SHEETS (Parenthetical)", "role": "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical", "shortName": "BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2021-11-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-09-012021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - STATEMENTS OF OPERATIONS", "role": "http://manage@cannabissuissecorp.com/role/StatementsOfOperations", "shortName": "STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-09-012021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2020-05-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Statements of Changes in Stockholders Equity", "role": "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Statements of Changes in Stockholders Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "AsOf2020-05-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetInvestmentIncome", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - STATEMENTS OF CASH FLOWS", "role": "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows", "shortName": "STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetInvestmentIncome", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS", "role": "http://manage@cannabissuissecorp.com/role/OrganizationAndNatureOfBusiness", "shortName": "ORGANIZATION AND NATURE OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - GOING CONCERN", "role": "http://manage@cannabissuissecorp.com/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cannabis10q_nov21.htm", "contextRef": "From2021-06-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 5, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "CityAreaCode" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelEmailAddress": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Email address of contact personnel.", "label": "ContactPersonnelEmailAddress" } } }, "localname": "ContactPersonnelEmailAddress", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r303", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "DocumentTransitionReport" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "DocumentType" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "AddressLine1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "AddressCityOrTown" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "AddressPostalZipCode" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Address State" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "CommonStockSharesOutstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "IncorporationStateCountryCode" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "SmallBusiness" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "TaxIdentificationNumber" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "LocalPhoneNumber" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://manage@cannabissuissecorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "auth_ref": [ "r134", "r139" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.", "label": "Accounts and Nontrade Receivable [Text Block]", "verboseLabel": "Accounts Receivable" } } }, "localname": "AccountsAndNontradeReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r11", "r24", "r131", "r132" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedPartiesCurrent": { "auth_ref": [ "r42", "r81", "r253", "r254" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.", "label": "Advances From Related Parties" } } }, "localname": "AccountsReceivableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r17", "r18", "r37" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Wages" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r35", "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r45", "r46", "r52", "r53", "r54", "r84", "r85", "r86", "r226", "r279", "r280", "r312" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r25", "r196", "r259" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid-In-Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r84", "r85", "r86", "r193", "r194", "r195", "r236" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by operations:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r78", "r115", "r119", "r126", "r135", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r224", "r227", "r239", "r257", "r259", "r262", "r270" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r13", "r15", "r43", "r78", "r135", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r224", "r227", "r239", "r257", "r259" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of presentation and consolidation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "BUSINESS COMBINATION" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r10", "r83", "r112" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "ORGANIZATION AND NATURE OF BUSINESS" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/OrganizationAndNatureOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r32", "r259", "r284", "r285" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash [Default Label]", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r19", "r74", "r261" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r32" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash at end of period" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes effect from exchange rate changes.", "label": "Cash, Period Increase (Decrease), Excluding Exchange Rate Effect", "negatedLabel": "Net cash increase (decrease) for period" } } }, "localname": "CashPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities:" } } }, "localname": "ChangeInContractWithCustomerAssetAndLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r40", "r151", "r264", "r274" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r152", "r288" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockConvertibleConversionPriceIncrease": { "auth_ref": [ "r187" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision.", "label": "Conversion of Notes Payable, Common Shares" } } }, "localname": "CommonStockConvertibleConversionPriceIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r84", "r85", "r236" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Shares, Outstanding", "periodEndLabel": "Balance, November, 2020", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockOtherValueOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Value, Outstanding", "periodStartLabel": "Beginning balance, value" } } }, "localname": "CommonStockOtherValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "CommonStockParOrStatedValuePerShare" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "CommonStockSharesAuthorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "CommonStock SharesIssued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r23", "r186" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "CommonStock SharesOutstanding", "periodEndLabel": "Ending balance, shares" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical", "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r23", "r259" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, par value $0.001; 250,000,000 shares authorized, 31,091,975 and 34,500,000 shares issued and outstanding as of November 30 and May 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal income tax benefit attributed to:" } } }, "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r48", "r50", "r58", "r222", "r223", "r230", "r267", "r278" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "COMPREHENSIVE LOSS" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "CONVERTIBLE NOTES PAYABLE" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ConvertibleNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockAssociatedDerivativeTransactions": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Describe and provide information on derivative transactions entered into in connection with the issuance of the contingently convertible securities that may be useful in explaining the potential impact of the contingently convertible securities. May include the terms of those derivative transactions (including the terms of the settlement), how those transactions relate to the contingently convertible securities, and the number of shares underlying the derivatives.", "label": "Conversion of Common Shares into Preferred Shares" } } }, "localname": "ConvertiblePreferredStockAssociatedDerivativeTransactions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_CostDepreciationAmortizationAndDepletion": { "auth_ref": [ "r60" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives, and reduction in quantity of natural resource due to consumption directly used in production of good and rendering of service.", "label": "Depreciation" } } }, "localname": "CostDepreciationAmortizationAndDepletion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r63", "r260" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r64", "r78", "r135", "r153", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r239" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Sales of goods from principal activity" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Goods Sold" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPriceIncrease": { "auth_ref": [ "r165", "r187" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in conversion price of debt instrument. Excludes change due to standard antidilution provision.", "label": "Debt Instrument, Convertible, Conversion Price, Increase", "verboseLabel": "Conversion of Notes Payable into Common Shares" } } }, "localname": "DebtInstrumentConvertibleConversionPriceIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity": { "auth_ref": [ "r39", "r187", "r188", "r189" ], "lang": { "en-us": { "role": { "documentation": "Description of the type of equity security or securities into which conversion will be made (for example, common stock or preferred shares).", "label": "Debt Instrument, Convertible, Type of Equity Security", "verboseLabel": "Conversion of Common Shares into Preferred Shares" } } }, "localname": "DebtInstrumentConvertibleTypeOfEquitySecurity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r164", "r249", "r250" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Convertible Notes Payable, net of debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationDiscountPremium": { "auth_ref": [ "r138" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of discount (premium) attributable to other factors on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), purchased with credit deterioration.", "label": "Amortization of Debt Discount" } } }, "localname": "DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r204" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net deferred asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r208", "r209" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred tax asset" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r72", "r147" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation [Default Label]", "verboseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r82", "r231", "r232", "r233", "r234", "r235" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "auth_ref": [ "r2", "r3", "r4", "r5", "r6", "r7", "r56", "r275" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "LOSS BEFORE INCOME TAXES" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r52", "r53", "r54", "r84", "r85", "r86", "r88", "r94", "r96", "r104", "r136", "r186", "r190", "r193", "r194", "r195", "r211", "r212", "r236", "r241", "r242", "r243", "r244", "r245", "r246", "r279", "r280", "r281", "r312" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ExtinguishmentOfDebtGainLossPerShareNetOfTax": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Per share impact of the gain (loss) on the extinguishment of debt, net of applicable taxes.", "label": "Extinguishment of Debt, Gain (Loss), Per Share, Net of Tax", "negatedLabel": "Net loss on extinguishment of debt" } } }, "localname": "ExtinguishmentOfDebtGainLossPerShareNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r238" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held.", "label": "Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss)", "negatedLabel": "Change in Fair Value of Derivative Liability" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r79", "r199" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.", "label": "PROVISION FOR INCOME TAXES" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyDisclosureTextBlock": { "auth_ref": [ "r240", "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items.", "label": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r72", "r169", "r170" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on Extinguishment of Debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r65" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Foreign currency translation adjustment" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r61", "r78", "r115", "r118", "r122", "r125", "r127", "r135", "r153", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r239" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross (Loss) Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r62", "r73", "r89", "r90", "r91", "r92", "r100", "r102", "r221" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "negatedTotalLabel": "NET LOSS" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).", "label": "Net operating loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.", "label": "NET LOSS PER SHARE: BASIC AND DILUTED" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r80", "r200", "r201", "r206", "r213", "r214", "r215", "r216", "r217" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r51", "r197", "r198", "r201", "r202", "r205", "r210" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r69", "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r71" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts Payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts Receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedSalaries": { "auth_ref": [ "r71" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in accrued salaries.", "label": "Increase (Decrease) in Accrued Salaries", "verboseLabel": "Accrued Wages" } } }, "localname": "IncreaseDecreaseInAccruedSalaries", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeLiabilities": { "auth_ref": [ "r71" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Change in fair value of derivative liability" } } }, "localname": "IncreaseDecreaseInDerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": { "auth_ref": [ "r71" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Advances from Related Parties" } } }, "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": { "auth_ref": [ "r71" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.", "label": "VAT Tax Receivable" } } }, "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid Expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r66", "r166", "r167", "r168" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Amortization Expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of nonoperating interest income (expense).", "label": "Interest Income (Expense), Nonoperating, Net", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNonoperatingNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Cash paid for interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "nventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r30", "r31", "r140" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, net" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsGross": { "auth_ref": [ "r16", "r148" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements" } } }, "localname": "LeaseholdImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r36", "r78", "r120", "r135", "r153", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r225", "r227", "r228", "r239", "r257", "r258" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities [Default Label]", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r29", "r78", "r135", "r239", "r259", "r263", "r272" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES & STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES & STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r38", "r78", "r135", "r153", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r225", "r227", "r228", "r239", "r257", "r258", "r259" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease": { "auth_ref": [ "r253", "r265" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in loans and leases receivable due from related parties.", "label": "Related Party Receivables" } } }, "localname": "LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r68" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r68", "r70", "r73" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r8", "r47", "r49", "r54", "r57", "r73", "r78", "r87", "r89", "r90", "r91", "r92", "r95", "r96", "r100", "r115", "r118", "r122", "r125", "r127", "r135", "r153", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r237", "r239", "r266", "r276" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r89", "r90", "r91", "r92", "r97", "r98", "r101", "r102", "r115", "r118", "r122", "r125", "r127" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentIncome": { "auth_ref": [ "r277" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Net Investment Income", "verboseLabel": "Net loss" } } }, "localname": "NetInvestmentIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "TOTAL OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r115", "r118", "r122", "r125", "r127" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "negatedLabel": "OPERATING LOSS" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r207" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "negatedLabel": "Net operating loss carryforward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance", "negatedLabel": "Less: Valuation allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive (loss) income:" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r22", "r173" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "PreferredStockParOrStatedValuePerShare" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "PreferredStockSharesAuthorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r22", "r173" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "PreferredStockSharesIssued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "PreferredStockSharesOutstanding", "periodEndLabel": "Preferred Shares Ending balance, shares", "periodStartLabel": "Preferred Stock on August 31,2021" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheetsParenthetical", "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r22", "r259" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, par value $0.001; 20,000,000 shares authorized, 5,000,000 and 0 shares issued and outstanding as of November 30 and May 31, 2021, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r12", "r14", "r142", "r143" ], "calculation": { "http://manage@cannabissuissecorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromBankDebt": { "auth_ref": [ "r67" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from bank borrowing during the year.", "label": "Bank Indebtedness" } } }, "localname": "ProceedsFromBankDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r286", "r287" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r34", "r148" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r20", "r21", "r150", "r259", "r269", "r273" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentOwnedNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net amount of long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations (owned aircraft and capitalized improvements) and capitalized assets classified as property, plant and equipment that are owned by the entity. Excludes assets subject to a capital lease.", "label": "Net property and equipment" } } }, "localname": "PropertyPlantAndEquipmentOwnedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r33", "r150", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the preproduction design and development costs it incurs related to long-term supply arrangements, including whether such costs are capitalized or expensed as incurred. The entity also may disclose the aggregate amount of (1) assets recognized for agreements that contractually reimburse the entity for its pre-production design and development costs (2) assets recognized for molds, dies and other tools that the entity owns and (3) assets recognized for molds, dies and other tools that the entity does not own.", "label": "ROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/RopertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r20", "r150" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property and equipment:" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/RopertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r59", "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for Doubtful Accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r251", "r252", "r253", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED/THIRD PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/RelatedthirdPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost": { "auth_ref": [ "r291" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed.", "label": "Software development costs" } } }, "localname": "ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r26", "r190", "r196", "r259", "r271", "r282", "r283" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r84", "r85", "r86", "r88", "r94", "r96", "r136", "r193", "r194", "r195", "r211", "r212", "r236", "r279", "r281" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing revenue from a transaction on a gross or net basis.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionSalesOfGoods": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for the sale of goods, which is a transaction between an entity delivering a tangible good to a purchaser. The entity also may disclose its treatment of any unearned or deferred revenue that arises from the transaction.", "label": "Sales of goods from secondary activity" } } }, "localname": "RevenueRecognitionSalesOfGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r55", "r78", "r113", "r114", "r117", "r123", "r124", "r128", "r129", "r130", "r135", "r153", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r239", "r268" ], "calculation": { "http://manage@cannabissuissecorp.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "totalLabel": "Total Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "REVENUES" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r210" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "verboseLabel": "the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "the valuation allowance during the six months ended November 30, 2021 and year ended May 31, 2021" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": { "auth_ref": [ "r99", "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.", "label": "asic Income (Loss) Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r115", "r116", "r121", "r146" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "REPORTABLE SEGMENTS" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ReportableSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r76", "r83" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r41", "r52", "r53", "r54", "r84", "r85", "r86", "r88", "r94", "r96", "r104", "r136", "r186", "r190", "r193", "r194", "r195", "r211", "r212", "r236", "r241", "r242", "r243", "r244", "r245", "r246", "r279", "r280", "r281", "r312" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r84", "r85", "r86", "r104", "r260" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r23", "r27", "r28", "r78", "r133", "r135", "r239", "r259" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityChangeInReportingEntity": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Impact on total stockholders' equity of cumulative effect of change in reporting entity. A change in reporting entity is considered as follows: (1) presenting consolidated statements in place of the financial statements of individual reporting entities; (2) changing the combination of subsidiaries that make up the group for which the consolidated financial statements are presented; and (3) changing the entities included in the combined financial statements. A business combination accounted for under the purchase method and the consolidation of a variable interest entity are not considered a change in reporting entity.", "label": "Conversion of Notes Payable into Common Shares" } } }, "localname": "StockholdersEquityChangeInReportingEntity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r53", "r78", "r84", "r85", "r86", "r88", "r94", "r135", "r136", "r190", "r193", "r194", "r195", "r211", "r212", "r219", "r220", "r229", "r236", "r239", "r241", "r242", "r246", "r280", "r281", "r312" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r77", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r190", "r191" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteSubscriptionsReceivable": { "auth_ref": [ "r22", "r23", "r27", "r171" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.", "label": "Stockholders' Equity Note, Subscriptions Receivable", "negatedLabel": "Total Stockholders\u2019 Deficit" } } }, "localname": "StockholdersEquityNoteSubscriptionsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reporting subsequent events.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r105", "r106", "r107", "r108", "r109", "r110", "r111" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r204" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/ValuationAllowanceDuringSixMonthsEndedNovember302021AndYearEndedMay312021Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://manage@cannabissuissecorp.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r112": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r134": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "310", "URI": "http://asc.fasb.org/topic&trid=2196771" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922903-210455" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "326", "URI": "http://asc.fasb.org/topic&trid=82887179" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105117-122735" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r191": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r192": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "http://asc.fasb.org/topic&trid=2122478" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30885-110895" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r256": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.7(e))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r292": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r293": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r294": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r295": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r296": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r297": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r298": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r299": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r301": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r302": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r303": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r304": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r305": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r306": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r307": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r308": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r309": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r311": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r9": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22624-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" } }, "version": "2.1" } ZIP 40 0001680132-22-000009-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001680132-22-000009-xbrl.zip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ⅅGMY_0QT-,5H%XJT$T#.):.F60 M["=M"CX/C-+!) #US\^ QX:$S?!T& HUQ$OB2!0,\$AX20S+_UC& M%1]F5,B7$#1*$^87NQ!YRKIU_AZ,8EV11%[$FA\MXF^ ]H1O_633/_1!O_(G M"IHCL51SY-N37YW?*:.G96X>8>7-A_O[0N,7T13-RDVULQJGQHD['!C1I%TS6HU$ -QFB)'74.51:T/PM['*@;-HN*N MA'ERL3$G28B;WG0<(]P*ED6WJBID,H9$[CTV;P5 (KD5&C03I\=L%:4,1=E2 M20 U*"\R4HQ&"C+F07=QZIBJ @YUR?4,0Y?-LD*'\S-+#?POS;6$H:*)Y"&B MLC1#TJGZF-ZK3 6?%GYU)>79U#8$'IK^$ ?6KJZE9KQ'L%_1Q! 9BPX$XTQ MIY)=9X+*>VZ,DBP=/;%/;142Z[D93I1)]9-MQ<"J7<-/,%/\.]+ZBB&!->D0 M7''T"6"Y/X9LVK5G4>]33$T9HB#+1*\W,&A^G=P19 _V;0&M,*,+J^P^L1J" M%[GHXH'CMXTE2+DK0W<9MCT1R]5Z(O\[]5-+A6$?_!J'.6N0N6I/^C\Z'>G; MC]_C?I8ZE./ M\D$6R5]-,A%%48&R+!=#[VX*A?I[3[?L_(R(6)S4RP!>31DS'UR[#EL9T,DY MNUN5I2YMQY?Z<#I5R ->NXK 'I<>99A4,WH:*(@@A6)@9T UY+K Q-0]3 M ;V[*\9@)%4Q>J;>(("0T<$C!?L!D+S3, 9U#M^F8&T%L'?:E-=-8Q'G;3!L M\ @\.CC(FED:I:$I+; D#F"9U"4VE=>4GUZ7T_F@X5JW#+,/"*O,J13WI?>S M#[8G?\O:'??K:5A+9:*D)-CV1.A_O>O=*C\?\_S%%P";<(H#^'ZU@2G3CA>T M1'0((8E0B/KX_(S*.Q%2,)U_#1%4F\OC(B['@'L"I\->CQG/:9HQ&)I,3-PV MQ-$B9,M9(2851(P;.%+I?<,-_1M$BI<4O^]*0_ MH%H6)'U_CY-HTWI#68LC^L; >GSH;P+.>AP<"G\O\'[!,1^' -UZ0?"Y8M6, M]&VV\XDH>Y:>S^?!V93L=_X:OMC/60CPCS^8Y)%CJ/7-J.<35S;Q_#U._'0P MRS8'^B2XOB''(D5UB+$17GVNPN98:3T99G'*Z6OI;,Y [[VV7M)\8DFQGN_Z M90Z( ^PY\'K=.K,0Q2^];.K"@&=+?O?(!LJSJ2::HR3)/G&$I?'K2GT'A&.XMD3G(:<0]DT$C-!I"S&OB@&)1%4GI MT'+EDPAK-RM\'>1RJ-$[CNDZ'B3],U@JTL0&+ %-(,$,@D M," ,]X1U;^M*V/3?]$8@DLT2;7IL:UC=R6FS5D' 8/4'I$@"= W)]JLC4&5F MZ0/9J:,C*B"8X!]@%P".Z/5!,!62 9>0H8&8QRS14OZ06S,NLVB"0) MIVGT3;H52VA")\2H,R:Y:AMF'HC9HQ_(7B]P(AEA$0M=0P=Q,?^B*+&&%/" M_&7MO=$-7=-LF(@#90@*R]P4_6,(/3/+YU21P*)('I'F#@TLQ) &[(0&8"( M"$]2B7BV5,3F++J/3G M#A?/J6#WJ,=%G2R)FC:>-P:&94<%/(1(0C2WG5')]1<)8)P6AJ0^U/$.=,W: MSW=%*(:&NX:$2'@'D)-J4].;(*>JR9F?.,$E&F"]3W;7RG/OG9_1%^V892A1 M'V5A.1S9V2>1EO;QN N=')Z/H6M25$<]).H-B2_D,VT=FXZ#&24.HQ8F*+4N MN(1 &8[O$^%NI4!X3QS9Y?,GXBGPY]^/_5M5 X) MJ2U7UBV.R"V-TUWT\S-:O0S.J0+2H3Z+&MGFUD52R4/$8EI*8F]-S\7WQ-LE MJ0]D1_FB-E=;-U> X]I7GZET-+([N@('9K7 MM8H%J&X<0GPAB1,LO*X\*P@/H)LLM*:6K/*E6O=.D7MW@#NA0'FJ8L=\%5GG MY)X(;J3Y@VF%5YMS]RT;(:J(]*( M:+KVPV1DK6P?ULR"90<:(C^20L[A$A* T)IU-22[B8DA)_4P1,I49#85-"N$ M1!44$0@AO6#!*DG&9K$/E56K+9==6#. :)<4,M,*7)XX""06N40U0W6G(4'H M[10)T1YSZ86A HI"-PO-Z82*2J5_NA:([ V^3V2=O"S -!JVP%XXW,)+U*LP M839+=EQE2F8.@QR L<" L7FS73Y!!0GR>$XCFDAQ[J B*+)+P^TL+!U=P -0 M3;IYAL3,0I#GK4=@=(6H<1C+J40VS#(Q9VY3EW(."&:1MXDTLS!^ ! A,\M, MOI$)NF/. $[.R"Q1Q+0%F1FKTOFLIF2D'!(TYXBXQ;7RLF0=E)(IDD< MN=*GG]*I['NKF$VM,!]>P)!WYP8"24ZOG.F.!EAZQD(%VI+-A M;*8XV$5EHM5GM*7HV"7-UBI3POZ;\9O-VWYGQ//0>/B^PK5=2EDARLR@WM'Z MK9&4R_[['*$]^=FK&_?YOY/?V7Z4;'JF/9%JX('^+O^^:J8NOEP3,7JTQ=59 M'7(M;W_&?GJ&@A3:RP)']E^+BD =7&HIWI%0/,%\*C2+]!/[Z;W)1+D$0_*U M[O7UF7[0>V^MN1'> M$ZOQOC=<6PBF"1;3V5Z#8^L4!$F_B/0E 1Q,7@<7F[;.FO[E$/$3T;G'0YED M1"ACR(MRX.R@0["B2Z2N%6(C9V.9TSFS3D:C#J!JQD3FUKBY/8Q(T EA#ME% M)HM5AC1.4IYE]\[XY?Z:2NT["6F'#S-QR7P/!1*+Q4R1@,#,"E/-X"4V33 . MN3'!!_V&7B;OG+"A\>W,C8UVSG-H7E:'N.%055ZL8T;TX-[47 L&MM*$\)76 MAV H3O)WYV?P--AV?3R_FZ\A4H,PHB4#+O%T(E5.-UT)E#3?=#]-DAE6[80) M%(@]">VG>0S7Z78Z-H3O-L/1U?#BD*0\)E M?_[X*@^YSF.DT@5L>P(PC^N5JVPSG[WXXEK"_M("TTF1.$U+6&G#:2I3MJSZ M=(_M_&R:T&BZSL[.&"?T@_A,,ZDS8EPIV]N5B0.2*%=)RI8F)[@>!.KF6#3? M;761LLR\F8:;FENG(XM5GDU&,=.ZL^^9#L1,+I0V+8 9:=,4RUNW$8Z0&G&1:YU8G$D>$;$.: MV[MV+6.7KH@D5J8["@I%(:TO-'V+\[,^%GJA. @'W)"T6Y=O6G2]_+7VY*E1 M892O7V]_]@[:', $N)=E MY_D)(-8&$'F*[-98'B)1168#..*_6%6^Y,R]^6,'Z\^D=\;2)@!SVR)T*]$Y M,;&B)8$99$QS_!0NDG#4S,T$"B:L2M3M=E&JV8SJF61D2=W4^E7/Q")F@126 M.7.#"]Y2:0SDWO.".$2B(2K\;*+#HIRERVA!S#04-AL2 "9(9SN SHTXFJ:8 MW4ZS]FPQK2L!@"&,%LRX")M;ID#/)<0DU5K3=9']*O>&K+,649M3HJZ2#FL) MIB(U8S4K;:E9FY> &;HY0^S6ZU*'#;,=16,J.'.MDL8WJJ+14VY8MQZ>JL Y MA5EP*W#:&=\WK7.[WM7#QQ8(+G9222;9&I(=HAHY M1HX( B:LZ@<#L*02&,R2 QN+=\, &)H>HG2!!# -ICNI]B.N-E_DL!9(S/S!*MXL&!)E:EM) M0ULS0>1F03+!Z#T]3CJ+*M?PYI:$74*Y9+6?3$/]#@:;\]!LP:#*X!WIIZF] MGV%Y#4;0:+1B!SL>$[PB3E=D:8[=9YF<8-K1.I82%76K/+X#-!Q/B^2L?05: MFF6=O%W4,];;]%G)BB]G%0I>5+_D)31 M]OF(QK087./!&Z-M^\#9!Z-A'A&PWY5)KS]'S4_MW4C$S]J,1)@^NB/X5DF M-T_.##8 R.WSX%3AFZ_:=T L'<,MK3,[ *2+EV./.<Z7R,'-GB'RSH<_V05!EJ;/[3'B8!IVL?T(ZRA()K$]B$3LI%DUN0! M+TUCO21#ALTP$ B,-9ZS8Y:5U"->UNL+;T MI?;D]T1LC*Z83/8^E);<.WCW:4-IM=(R"4LNOA2M0P0W5 $V%4G8GW-OSVTJ M7WKHPHE*S0U]JZH2GB%5E;2TB;:RCMF_2UR'U S#4Z1FT"KKE373I\7$'@"# MD,W+UW0JL,GWL6!(I'NGE2>M8[79!^U$&NCR5V/0( -%+DJ;'>Z\Y),RJ49K8!Z*:6&:^1A$1@Q8 :7) !D)G#XKA#9 [SVTAT?QF MV=0M,O^]KF%PK[@X0^BF'V9=16>!65!<*8X-$:.*&MWPV?&D)W$S'<=*5MCY MP*I)R2$4FTOVM$I/THF9 -R95\KB!R)*(>Z+\E0ITSL(&B>9482Z+$PKE>6R MN/+DQ,2%&FY+K3M^)HG2>,Q@!$-O._TD0:Z7^H0<+VV7X[5=.5Y;D'2XR_': M )<$S%0**+J.[6#\IA=BM,]V5,A(\(N^ZF;TJ9"_4\_R?K-6V"1+YN1FU+_N MY,N-BEDHYC$XB;RC2#&_Z.I6>K^#@SEL.&*S"!:F<,NM7N3)D9].*@F?^D79 M=DA0D!GD8J/?),!G:%'>?GBQD3\)'-S\U#Z:RN82AQ5@,WYTK+OO'QNM>BD- M+U?Z@8G5^V[ ?AWHM ,GCM\<5)MPA_O@P.[6'(S.3FTN*HMS\I?J!\VHC5@+MH:<%S -> I\TY7O_2_=%N5SL'[#Y?G%Q_P(*B=7E],P>-] M";U$E]-E*FP[HP1=9T0*&7%OKV])$ J1D&<0B<:/! * A%C9TLJ0$$2Z0$(@#R7I+P<4#[A5TF0OJ96&" M'H/8Q50GS_'=%FMN$\S"\Q%GR>1%JY1Z)<%,<*\R"X6QXE;4I/R"A?2 _:/) ML6(FX;#!(%(H>G"=!-E3=!2^N"O/_IZ =^ 139.2+2;)N]W<^R6$/D6Z8&'. M0!0$R>P2X&<8?22WC9 @V2X'M384'@^7=VD"VXP!1S,4^1V96(FO#B1 M8FP6^D2C[32#RR]G8L%'K"DEU;ZYK%Q+4"MHJ1F0R_-;B)"*V"&B+2,&->VA M0!M!8NKW!.3BP@/DH@ATAC54[EG> ^^B]T*9L,%Q1@(7!1P9W\Y/#M4*W"6! M0#TXOE&_@,YB[@UTW,HIF@%IX&?4K1D9_R9,T<20;8!_0Z"U\(=00_/^54=3 M1K>-6YUA6G"@',S%L9RF#@P(&V<[O2%&MCS7I]9_')W85;P^;SZ*([('%.KK M/$3ST12>'+A"D[M'@N2Z=]!_0TJ(]P+#=T\T+Q-\S+"@I3FSA'J>7Q&E4$(" M28UAPZ@ZSWQEJ )\P\+M$\3+4 JNE-(S[E.2]*OQ"&<.8@>#1 3C,\"@6UX) M@#"'-F&7X7*8&E*HSR[E1O/*5-Y0-S+P_AX8X'K0C-+#LY##]@PD>HF35B>H M'9YJQ[/K;([=U,>T9MQXKJHF^(3C*"%&-J=NP"T8_/1 S_STS;;848D$.BF* M>/WT5/Z0XPH F0QVKY:*O8"T%!I1Q%>5JJCW8E9]S6B! M!C-UY0M,]=90/J+M8\>.8AAB%-(6,7U869[Q>+"9TK8H,8BKA6 *[ X0KF(\ M(4K^U*!.':23";< TY$'W!:A%JZ&1_:Y8QM*%QC-949XBRJS7J,C]@V=!W'= M8T,%_=0AE'"$#Z[SH)R!7D/0^0^]YE\B! ('8K@6>:6\22?PQ.2R@2AJ-I/- MTO_1)N#]%H, ]>22B$\R2H=(A@>&A18QH;@-6< )5VG!A8:WU;1;?J_)C$>> MBMT$;CS$'0*QA;&FLA!:H$W*+G3N1/F''-Q1ZAA>B7N2RH@$%&%%SH-P MCH21;CC!@U"21!!.!8I^NP:8]K/%J#^EZ;" HOX2)29&< MJ;!'RR# >,0H-:09+3=E#OR/)MVN_U .\T>3350G=N::8X15: WS2]HU5)TH@/%2]JJD@HFVX9N M58*=^E9MH!RE?*RM?9?RF9RZO9MT&;CQ+>Q(P9:,AB)">%,9_-HVC1O<(HFJ M:>EP,U+!:J?PW)-MQH1:LI@IE]4-W-:<>E1*L*\-!UV0/,NS$=Z=UXASR/9Z MMH&YSCW7\L5,MEA9'1#BZF#LM)5=Q1?(GL=W*Y8 MXU/3L4\(-PP^/@EC?UB4Z(W%::J)^NDE>O/-Z/'V_N_C']EBNYA*LYU%XSF% M("'K:CRL4[H9=8^=LM//6?_4X?O7EU>GUXWO2O7B1#G]^^OY%?+16N,Z*V2< M*7EYE42]%F6@Q2_:W6FC:'GM](#4@MD=%V]&>?OL9S??K7CNM-Z%?XRGQVZ5 M+QN>P]G_>1"67#W11(N6NT5L0T'1?"5W@ZRDJKGLS:AR?/G)_]ZT^_6#*=;C M\9*LQV2>4SP#QG/LF$0NW^).1*P\$2M;R*DW(^O;A^S%G:=Y=6UCJ"5798X3 M*G+9"I:4/4LB[P3\=6.>WXRN*__]_D$OG>D?.C'7LAC6#L0DKST]*!'3S7YB M^SK8!?P'CQ2M;YOL!5_K)W"3*F;R!5784&):LV5\ MMXLI[&*V<)A34]S%*0HH)RF@H(6KW,$U5#Y@>]Z=GAQ_^9DM)%4^*2J<^'ZS MB_/M\@^L%;AH9_/?]'U,0X.4,[E"?@D*9+<1SU0"\S=BB@XH2CJ@&E9.R_W$ MX6?+(%!2NUWM80GYB/X^5=7=F!?G-VWS9N1\[?]S75!/*H40UR55+W,2Y5&= MTK9YQ:9MNG9K(@9^/9N#E\4.:2@>30U;?8F M3E%;B?QHEP^V@8C)9,&XG_+M2G7H-'(_-D<7X34;^Q#%.E/2NF\OP=9>)\,_ MT?X6S)"&-LIE-"V[F!FTV[OE[=VSE% ^DROG$EI.8=QT1C%[M7(S&C2:C[5< MQ?[KJK65Q>QGO)J2]7&=W[69:A98M^N8ILVRE17 *DXV:RZ4-7K7JWQ&+>;& M.C>38EL*^U?-)FTML8YD)@1I.A,('DU:A" M[]:P6^8<%--L/H)BFO0E-Z/N9UU3C=JWQG^7B";PQ$JDHHA<<;*/1:_4F]%' M=71]]6GTW^)?^L'[VN67+^<-%OK$"%;M\J)Q?O'A]*)V?EI?210K6&=,5=JR M1YE (0RP0<8+[A5>Q!(VE7I9,L(3W"F_O1$B4<_ONYXM19I])'[+S4A1S0Y*1VLWHJM6S>L5OY>XG6/[UZ6?,%WC;^.O\^D2YJF*T MMW%=O:A7:UC#MQHQ60\N?5!4')8@H7R05%!Y$L?-INHG5E;&JK4XZ':&.J@2 MQC=,I)U1HH@ZBM_'O[Q261%4,IC0NF\;QJ"K*Q?8^,/6E;IIW<._?IL:&F%Y M&A^^/3[<*WA+L^BJ;] Q<>OO)51R!-ET(P<0[,9J#!MIZTP2Z&CGU9CQW M,_JB=R[CXN=;/.8NOIU>-\Z//Y\J+"'H MJOJ]"K^]--F]M)43H\6D1Q7UMTDD1E1MUJM75>4\@!>!D3]_KJ&$4I4B"">6 M&5H.4!MD*[ZPMR%7QA([,S0&IBP\-%09&)=%G74F1MS?PR$9_ 1R(XFP&%(@ M#U,Y)KY$*65_.\26/V3KRM-0^]@ TE=PKA!/@>E M!#_EX!* -L&*_N$?[>R%G* ^($>&[GJ\SZG[&5X2[ MR]"8ONANJ\OX32V2=OUFN(C',?[%*NR(I6BL#G;+*2N+6IZ)VN*2]L%U_/Z* M9$P::^#L[ZU9NI2=<.V$*Y%PE9X@7!_J=<;OJ8M6=*3PU&(NI)U@[01K ]+P MX^W#[!,$Z\(QE88!=$M;KB(#[<1J)U:;2-F@D"NWB85<^5TAUZZ0:U?(E7HA M5]K!"_GT9DJ3.T,7NV\:;M$ M)*,#&\.7V:.L&G:E.E*.#9M:FU KJN [QC4YYF.*;$T OC$KE&!40"?[N^] M4BN98DG;SE-G=YZOPD[FDE9X@JA%C>3A)NN MT\:>QP)XF.%W#N(% .N-EL*3/J.CP>RI;?@&]@XNL5FZ1G2A+A\L:Y@IA>@/>)MO=UF MT-="%IW^"VF 'C93)BL:>PGTX#ES9/ 6W[V^8XLN;3(6?, Y$CO('?-8!SW[ MCN@F=ZN])"B9+DZKQ.6H-_A6D6&Z>(%M3"UR@MS: M19:4!!!IZD8LMN0DB>$DY4Q/8W?>6]8P/:DR7SIU9M;(I['AYZ "P-SZ3]-5 MWL+HU)DXS65M$VW.=-,5A/FF6WX*A$DN#:#88$FW+JC_-BHWQ_T#>Q<,C.D@ MP<6L5*$[=U9S2L_%,2\=)TFJA-5%IK XKIN\P=*(:;VZ-/;N9%!_N1S6&(MZ7M42&34PMI[M#S!/U?M=KIZ=E9 M-$>YIX$_#?0MIM MZD +LY%&"*[4FLLRGOM\2O*YE-6OB(1/$,#%1>^Y1)\O<$^A5KK(B^N]?(9W M3[D#A*>0TRWFYGF+#H77V,WO#4*R.EB&8[19#PBI@RF^J@.&CG)/%HZXUL^S M?)7F4!D,^X;4E HF"O=+YH%@]4S4>6EN&5&J%] (%UK& ,R^0W[W_$,YS!ZI M?8F#-A%22Q(,UWE8W.Q-L:CV>7>GP*4A,RIGZBF=)F((D'AYR:\2J2)8B>JZ M!@G(%R88IR@8*P/S&(_&;@0]ZJ FIE%#MIT6N@4>+TTS)_L.G=]DTD9 M9TPO8C1S%9RKI S7]L0[<_&YTWH.A(:@3;JD261Q4@)-#.,E7(*6-DQ:\@8A MR_U7S>0J!>59V .ST.6> 6+(R;9>_EL!=(.@5-JS5#/E_%3-MU( E>0.@K0U M5NS]<]VJ*HW)O3 =%$N:95HXBRN?E>_69O/2@MJ&H@]TF88WV,Z#J_K4JW7E+):4 [Y=,WW)U(Z"'I@_C+:,.KM?]Z:?$FB\_=<_\W P>[H+0L3 M"SLFRS\9RW'9WVOIKHN?P>1"+V/4"8EX06Y;SE_AC=8ES!//X#DNZ"M /P%\ MK+N6H]1- MW#K*,O3MNP: #V^\!H=6WSIV]0:J\T>B1M25IFTVCIV,#*Q+;O MEFG<"[(.,#4R>)UB>B+I!I_"CK^619 L0(86YM,!1?Q>GTUBV,.1?ZW MF)5Y1TK=;W4I!Y2/Z_%NS$8&4XK@,0>HX@:S"0 S,$-,FBY\U'*-MCGY 3$3 M?&3P=36-KGYO.BXYF5&D&#DP0\W5@Y[R;#S*2V))8TH/=Q$3K5I=3(;B%*%G M8):P2%@1=;"G\6 2AX3IX>H#T59Y%GO Z/(VZB#,]\ TS%T=PSHR3W#!\+A_ M/&@2@ALJ[S[1#A<7I79 !&)'I^D9+K6W$TLT[38\/P"*,0PN6=3@:3@16MVP M. Q>83SV308^02)"OQKMS 1>D(\$&W'9@$P;=&PL!,"(&W^,R M8_)EFQULK&VWD#*#!\-@ 82?OH/"&2EE8W$)B:B8*AHVZ=;[?0O62R[V,'.0 M'MW*(L:7,X":%TDO3ZCJ*NZJNGZUJJY=T=4:BZ[JD8.'#E-V$'N^A3_#"4F! M6:P!"&RG_;V)TQ&LQI;A>61!ZAZ//8<)PW%&!3-9X)3'LP .@J;9\=T6!9F# MX>3$>9;SSO+6A?FP/+WE_(+Y[G%^'=7DQ2F:;\])08TCA65 MJ"O)AN5G+>IM_#O>DHI:43,)L=@>+KXK6(]5G).[LX:XJLTUW9NNVF*WYG=FZ669K M"9O@;+S.;-TLL[50F%W_O 6Z=%L,5[6R,UQWANO.U4D0G M*QFNVE&ELC-<=X;KSG#=&L-U,:R8G>&Z0G,JM[:7W;HX-NT7F_F!S*IL *S7;II'V: ?(TS;7KL^7-M^O3KB0,JGX+VURS'!U@@7KE\JY>^5>K5TZ=&7<%T7/= M$RN"S.8P+0R[PO2PVUF+(;"(@N;]/;FBF7?"$MC8$F:,5%LMPWI(?9:FEDE/ MM'2BMWS1ATJ.=\I<9:>LS3 4I;,V!M0Y%OWJN2A7JQHG!DOW>>,\Q9R\8@V^ M9@!+[\@Q9B#/GG,"=^#*5Y70A;@EJY$5XE+!GN-6PM55H9PNS/&Q;K$31T=( M,5#3-IY-Q>W M;E*F].>MJ=G!Y'3[N4_2")A&PQS^9$6_GG M-FA=J8I=[7P2R>1K:K"0IHAM-I$V;3[)-JV4J63S;U9U=+X();E[]Y8<2FLZ MB&2WJ 'GSC,%9-M^>W#UJY^L0^S[/Q"W;;NH7;.ND-3YYKMG0% M]")T^.[=ZSHSUY"^AUE.MF-?^#UX2^O]?R*_4LX^O.O:Z/QY<.8Z/8R('F:+ MAUEUX-#/JGJ8RQXHAM?2^YB.Y?K&@6+K/?C9]PYO=;W_1[W5-=J^95QVZL8M M-I&Y-OJ.BTVCSNV.X_:HW.)XR#]LP'#'EM.Z@PGW%;/]Y\%C^_&FG#V],?@+ M#P^?^,:;T8=FUSS[_G![U2^.)Y8LA\ 1545?:F-+*9K0'PI80(9KF;9Q0.E1 M2D7Y][_*FJJ^4]ASP6HU[6;4*N6MIF';S4[IX/WUZ=7E=:-Z_/E4J9]^H)2I M0./Q_[R0+A)RNRW1^L%C&ZFX8INIAU$+>W6A\;:_1TV\L,%8P^D#UVKE;$;Y MC_F>,X 2L >V%CM2JMAMB;6E0'L/LZ6:O@?;XGG \+VF:;,*('IK3;=MO6EZ M2MTW/<]0/G^NX>B8(J!EU4JDQ]'^'C8Y8EE;;<4<>(H#QJ1.,^9KH%YEU#K+ M"P:/&T(L672F'_].S7'[XDNPHL[ <"/?V]^37A:WNLC$_\]3:J>7F!< 7*C# M8QZUZH#)DSAACR5RRL!VM-AR@'R.[Z+AW-0]6"QOL22W9PLD<7^/+11F,WAP MI%T4-%EETEE:+#MC#TW1$XUYL%K!%K6 RG6 ]1#^K:!*5RSZ?-N;$H=.' $ M&D-G%Q/7:+F&SMN5#9PF2@!V2VG[+>XUZQG8N,M2:L[OX?3Q1?$LED+&NL: M!G'E=F]J+"7@5\.^U6_91HXU7R,V1Z$/Q T[XMVS#H1-:ICWTX?!,244GOQ: MKXKJ0W@.=RS82G@<)"[<-]BSV=3\RP#F0OL6UNL;:R0?NV-<&*BK[PT;N]8- M)P4^Z.7#FMTAXWGFX_Y>#X;O(HDQ#CJ14D;?8_QK>E)GH#0:]6QA8=/ Z<]Q M\C\S9VZ6-;R XW>\D_LFQTUPXG7@&;S;=3-HXVS=)%7#:B<]S,GQ7E,Q; MRI1*B;#]=N380'(\(PE]&9F$ORPIGJ[T5JCH/G^NS:1<>DG?8Z&U8Y9N$B:; MK"-!;S8KKXP6S1TMUL,7JIK1M-D1\Y?)!(5LIES(;KSVFL:K#6>@6\HU<\"E MN'U+3"58*5_/MU@VABXK9?LMHLO+TH/;RC"S]&0:J0RIPZ8PK?O!=3P/HS$= M<[#2^,4NP+ M?JM?QE.Y"S"\_$WV+V_$Y 88MW\9?1&R7'#704D:8V44- M9LVBF,GFYE0?[,@1,Y.TG=2;08Y=U& 7-=@R[_"&>,17ZO#8D#6O=)]?JZ5, M42W,KA5_F=O]NJ!F2I7RU(KKC=%(LR,!S)_U^C/\^T:Y(K?6=C@S5\KG\RV2 MC:'+2H5@B^CRTO3BMK+,;+V91F0@-E]_V:^G2A[<_BGZ M#ZHN\;!S]>!4>KPG?]+.=7 5M,YU<&^'&T)Z1-YPL4E[, M5 K:CAZA[50HEC;^]K"Q_HQ?\6Z_OC5O)&_.OMDRBVQG@3]%$?^:A)FAD5\//1U"/F5O1O^^!X'_<1_3!4!ZC]FP%MF^HA3B;;A$J&8W%9744N9_3WF9L,4H6-' M=PDTY\1TC=; <6%@W7+L6X;JA%_IZ3\<[(P-8P1LER%@(T+J&73U 7VOD,EF ML_A_I>\:'<-UX4.OJ\,7V;ON'8:(A.8'>@'W]U0$>8+]AF]9EM)D_?ZH-1\C M7]VW#0/>KUSH=ENW=:5N6O?PK]]&Y)A;;!!H*W"Z$) 4)1N'_A_M[D)AINL$- V8^^ M-52TL!WBJNF4OJH^)PCUAOYX!?9V:SA-,ZN29I[VR,VHW,I=]GY8Q1\_-P%1 M3U6%DAU7KZ6;T?5C_\2^*MS]N"X?O%?.+VJ77TZ51O5_IRO&TEL1(AD'T=/; M3G_ P+NPIN'>I-86J!I]N%JX QV1K/1'$ R'@7I1D (,;Y -CP%=(;)>*9\] M5+.'Q<*A&HN@9_;Z%N%^,3@S^.O84Q' .<0RI03II/]^6O@YS!95J&QWS90#'<8(@9G&RFIW3A0 )5)O:XZ;.ZE>!1TGHA$\!#>M/QV9D' M[S19>T#/AV]'WGVDP+SW]R9VT@L;JNNMEHOJ5.I).W4/65,'_J#QV#=LCY74 MP$^Z1>!I\(T02)%_Q3L"VM#L]O>"QV%YX5.DUZ5!VWZ O<8@OO$\]-"@;].2 MI*T@IJ1%Z)9'5 N7%IF9M$/[>V*+(F_CIAL0>@#4&P72@0/9B/T6+,S"+(V6 M[KI#&/ !S9>>/D3KP;(-V#E1B'6W)8+143A\Y.<7$1,7K!3 M"$=,Q# JP_^,$Q3E <@E'%&:5LSDU-R,=[--PQWA9AF79SXJL?5> M(1\0KPP-W>7?D-N*LMGEM4RADJ?OO2J7,]EBF0S0OH&;"3M^Q,A]+H-RXN"@ M+)&7N*P#*[2%38.2I9-7%,QAH+Y^2TJ908[BO0KDWT#A!^Y!\>\Y+FI;8B\P M(6U@_ &S*CTX\!4*N#T5@S%FE0L(CA:_B.II@E2!=WV:+6"-05 M7X(0AQFOA%FVC3Z2$-;A]SG2Z"VH#S=XO.,/X'Z(3Y'OB+]D0N))E9 "Q&/& M04!2HP=KU-VATC8[, 6#F@$T#?8\5WN6P9?P)8Z@Q TNIUO3%B5. M-A-% L[C']39!K1ZW HR#/\5SP1+9QU;O0&LVKCE:K&GW[$54FH!L@A!;PHI M?0$V_K& EQ4$#_:<(\)$&/'!LEN#O%QX!10E3XPOLM M26'87>N/-Z$NU5&R4'R];I4X*MV-D;^ /.!$)6%R@B4?MSK%[\'$5 MKNRW9D^[^-*O#S2X!\NF Z@'7!4_.$@CH %MMV!]@48,E:!!B.)]'TU\[BRS M83&H1/R! V>JR[6)IOXFU*NL0AG#XP@NF;#CFI![]"84HJ*[1B( X 19F MOA0G/98^U.3C\L:\.+]IFS>C_$4]?W[F.,W+PL%B@I5BTLO%;"ME0],Z4LTH MYW;"F8M^#CB'HD?^](T^B)@45>^R(YL1K$7%GP?FX^ /V^^UG4';:,']U#I0 M^ \>J73?-MD+OM9/#MX'AJ#PU8M9O=_48H!MVIILX3"G/G5KRJ5\IES(S]Z8 ME2>ZQ?NVQB@)1_^T"-9II\,\0F0VH5&5QF[//^;766X#5M]ONU5/.?2JTJ$W M<469=0J>WXP>KWNY7-?MZHW5'(")A.'@_++U-;GMJU0BJ1C*O_I.I:)GIEO.\7?N"74)EUFR M,T:7CQ]_6EJA5VIOE#+!RW;@ TW-T-CR8O?(IX>>T3HT'P^[9KMMP!N "33S ML>E:V4*Q(!<5[C.R/M0KE4JO<>%UTXH$ M!X'\\9!O[6;TWU'1N7-/_-Q_FP?O!_%I='*Z5%(X\RG9;2* G"S);86\MLT1 MW'2BJ]%!THD2A\''(@L^%K/JC13+/2U\*F;_\3]4.L6),^>7CM56D4C9D%PL M:OM-_>>\U?GY_6NWN19R/2$J6Y#T: +M68-13=N'Z?)KL6-[U2:F/K;@,GE\ M,VI>%3^?VKE/EW\7-R=L*Q+II!07GN2NZ /6V)URX?_8*A?J"WCQ%*8L310X MH>\%C8XX_CLFB_J8HWKAV#PC#],) MQ8/D'AFUB[6OER>UTEGK=G/8.28+H0.T(0N-$4=\#-39T,O^^L(&ZV2H@\16 M].:'AG9,L$PFR#(F6&M8JBRIW4G?]KC_N$;7FG.[2LFB-Z/ST=GIY=7_!B>- M[N:HRETH:GZ 8]&M7KX2\V M?QX<[F)4:]W"9ZB@*1NX>.AJ4_0&FEC\BK"A M9^=+[3#P(F@2%PX:AX\8_UWR;E9+-Z-R.^=A"/ M_*9'P:/!Z3UZ,Q@TQFQ,#4WV)R=Y_F94N1IVOHZ.O6,MC1JBQ1$VM&D(&V /$"4BO,-I'L"FH5-#6K2&B!F"1?7C-5;S@ MR?V]@1/C%>=E3FVL?&(5JEBXBHJ!D! Z8+K;+5.W%"JU[-'@$@(-J_B-JV U M!_1G+)YVZ7EI)@9?A*.T&5C66'G4E#K@)Q#XTE9.C!9;9E>A7;UTC*,$>4.&K'@*; M,%J1%>Y-# ;OA6?PU*<]PL'8WQBD$L) 81V;#KOTB#79?5 55+_V*GN4S1:P MB)R!!K&9.*"Q83NMX$7QDR:GR1?W2*8'!D;ZONOY5##L*)_Q#>'*&*\0L-7^ M'I%9+1)C?#/<)N*>CGVS"C.U%(V^6.';?315%4H*22V#@JE]>_S\H?R/D4M% MP8O<(VT;: U]M/77=AD2S2\01KM[SD$'\3^ D:F MB:@WS>$4X^?UF>/VZ!4?#+1UZ*]OE->X35KVW8.1H9_4=PK_B^^-_\7QW>!/ M''R)?R)!'<"';S+[>V1K#

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end